- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03660826
Prueba de la combinación de olaparib y durvalumab, cediranib y durvalumab, olaparib y capivasertib, y cediranib solo en cáncer de endometrio recurrente o refractario después de la fase anterior del estudio que probó olaparib y cediranib en comparación con cediranib solo y olaparib solo
Un estudio aleatorizado de fase II que compara Olaparib como agente único, Cediranib como agente único y las combinaciones de Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5363 (Capivasertib) en mujeres con enfermedad recurrente, persistente o Cáncer de endometrio metastásico. Un ensayo de múltiples brazos para mujeres con cáncer de endometrio recurrente o persistente
This phase II trial studies the effects of the combination of olaparib and durvalumab, cediranib and durvalumab, olaparib and capivasertib, and cediranib alone in treating patients with endometrial cancer that has come back (recurrent) or does not respond to treatment (refractory). Olaparib, cediranib, and capivasertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Testing the combinations may lower the chance of endometrial cancer growing or spreading compared to usual care.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
- Procedimiento: Biospecimen Collection
- Procedimiento: Multigated Acquisition Scan
- Procedimiento: Bone Marrow Biopsy
- Procedimiento: Computed Tomography
- Droga: Cediranib Maleate
- Droga: Olaparib
- Droga: Capivasertib
- Biológico: Durvalumab
- Procedimiento: Bone Marrow Aspirate
- Procedimiento: Echocardiography Test
Descripción detallada
PRIMARY OBJECTIVES:
I. To compare the efficacy of single-agent olaparib and the combination of olaparib and cediranib (and potentially other combination arms that may be added by subsequent amendment) versus single agent cediranib as measured by progression free survival (PFS), in patients with recurrent, persistent or metastatic endometrial cancer.
II. To compare the efficacy of the combination of olaparib and AZD5363 (capivasertib), and the combination of olaparib and durvalumab (MEDI4736), and the combination of cediranib and durvalumab (MEDI4736) versus single agent cediranib as measured by progression free survival (PFS), in patients with recurrent, persistent or metastatic endometrial cancer.
SECONDARY OBJECTIVES:
I. To compare the efficacy of single-agent olaparib and the combination of olaparib and cediranib (and potentially other combination arms that may be added by subsequent amendment) versus single-agent cediranib as measured by overall survival (OS) in patients with recurrent, persistent or metastatic endometrial cancer.
II. To compare the efficacy of the combination of olaparib and AZD5363 (capivasertib), and the combination of olaparib and durvalumab (MEDI4736), and the combination of cediranib and durvalumab (MEDI4736) versus single agent cediranib as measured by overall survival (OS), in patients with recurrent, persistent or metastatic endometrial cancer.
III. To compare the efficacy of single-agent olaparib and the combination of olaparib and cediranib (and potentially other combination arms may be added by subsequent amendment versus single-agent cediranib as measured by response rate in patients with recurrent, persistent or metastatic endometrial cancer.
IV. To compare the efficacy of the combination of olaparib and AZD5363 (capivasertib), and the combination of olaparib and durvalumab (MEDI4736), and the combination of cediranib and durvalumab (MEDI4736) versus single agent cediranib as measured by response rate in patients with recurrent, persistent or metastatic endometrial cancer.
V. To assess the safety and tolerability of single-agent cediranib, single-agent olaparib, and the combination of olaparib and cediranib (and potentially other combination arms may be added by subsequent amendment).
VI. To assess the safety and tolerability of the combination of olaparib and AZD5363 (capivasertib), and the combination of olaparib and durvalumab (MEDI4736), and the combination of cediranib and durvalumab (MEDI4736).
VII. To assess if mutations in deoxyribonucleic acid (DNA) homologous repair genes (assayed prior to all treatment and prior to the study treatment) are predictive of response to olaparib alone or in combination with cediranib. (Integrated Biomarker) VIII. To assess if markers of angiogenesis in serial plasma samples are associated with response to cediranib alone or in combination with olaparib. (Integrated Biomarker)
EXPLORATORY OBJECTIVE:
I. To compare the efficacy of the combination of olaparib and cediranib versus single agent olaparib as measured by PFS, response rate and OS, if and only if the combination is superior to the single-agent cediranib arm.
OUTLINE: Patients are randomized to 1 of 6 arms.
ARM I: Patients in reference group 1 receive cediranib maleate orally (PO) once daily (QD). Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, computed tomography (CT), echocardiography (Echo) or multigated acquisition scan (MUGA) on study.
ARM II: Patients receive olaparib PO twice daily (BID). Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study.
ARM III: Patients receive olaparib PO BID and cediranib maleate PO QD. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study.
ARM IV: Patients receive olaparib PO BID on days 1-28 and capivasertib PO BID on days 1-4 each week. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study.
ARM V: Patients receive olaparib PO BID on days 1-28 and durvalumab intravenously (IV) on day 1. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study.
ARM VI: Patients receive cediranib maleate PO QD on days 1-5 each week and durvalumab IV on day 1 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study.
ARM VII: Patients in reference group 1 receive cediranib maleate PO QD during 08/16/2021 - 06/28/2023). Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study.
After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 3 years.
Tipo de estudio
Inscripción (Actual)
Fase
- Fase 2
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Ontario
-
Toronto, Ontario, Canadá, M4N 3M5
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
-
-
-
-
Alabama
-
Birmingham, Alabama, Estados Unidos, 35233
- University of Alabama at Birmingham Cancer Center
-
-
Alaska
-
Anchorage, Alaska, Estados Unidos, 98508
- Anchorage Associates in Radiation Medicine
-
Anchorage, Alaska, Estados Unidos, 99508
- Alaska Breast Care and Surgery LLC
-
Anchorage, Alaska, Estados Unidos, 99508
- Alaska Oncology and Hematology LLC
-
Anchorage, Alaska, Estados Unidos, 99508
- Alaska Women's Cancer Care
-
Anchorage, Alaska, Estados Unidos, 99508
- Anchorage Oncology Centre
-
Anchorage, Alaska, Estados Unidos, 99508
- Katmai Oncology Group
-
Anchorage, Alaska, Estados Unidos, 99508
- Providence Alaska Medical Center
-
Anchorage, Alaska, Estados Unidos, 99504
- Anchorage Radiation Therapy Center
-
Fairbanks, Alaska, Estados Unidos, 99701
- Fairbanks Memorial Hospital
-
-
Arizona
-
Goodyear, Arizona, Estados Unidos, 85338
- CTCA at Western Regional Medical Center
-
Kingman, Arizona, Estados Unidos, 86401
- Kingman Regional Medical Center
-
Phoenix, Arizona, Estados Unidos, 85054
- Mayo Clinic Hospital in Arizona
-
Phoenix, Arizona, Estados Unidos, 85004
- Cancer Center at Saint Joseph's
-
Scottsdale, Arizona, Estados Unidos, 85259
- Mayo Clinic in Arizona
-
Tucson, Arizona, Estados Unidos, 85704
- University of Arizona Cancer Center-Orange Grove Campus
-
Tucson, Arizona, Estados Unidos, 85719
- Banner University Medical Center - Tucson
-
Tucson, Arizona, Estados Unidos, 85719
- University of Arizona Cancer Center-North Campus
-
-
Arkansas
-
Fort Smith, Arkansas, Estados Unidos, 72903
- Mercy Hospital Fort Smith
-
Hot Springs, Arkansas, Estados Unidos, 71913
- CHI Saint Vincent Cancer Center Hot Springs
-
Little Rock, Arkansas, Estados Unidos, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Anaheim, California, Estados Unidos, 92806
- Kaiser Permanente-Anaheim
-
Arroyo Grande, California, Estados Unidos, 93420
- PCR Oncology
-
Arroyo Grande, California, Estados Unidos, 93420
- Mission Hope Medical Oncology - Arroyo Grande
-
Auburn, California, Estados Unidos, 95602
- Sutter Auburn Faith Hospital
-
Auburn, California, Estados Unidos, 95603
- Sutter Cancer Centers Radiation Oncology Services-Auburn
-
Baldwin Park, California, Estados Unidos, 91706
- Kaiser Permanente-Baldwin Park
-
Bellflower, California, Estados Unidos, 90706
- Kaiser Permanente-Bellflower
-
Berkeley, California, Estados Unidos, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Beverly Hills, California, Estados Unidos, 90211
- Tower Cancer Research Foundation
-
Burbank, California, Estados Unidos, 91505
- Providence Saint Joseph Medical Center/Disney Family Cancer Center
-
Burlingame, California, Estados Unidos, 94010
- Mills-Peninsula Medical Center
-
Cameron Park, California, Estados Unidos, 95682
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
-
Carmichael, California, Estados Unidos, 95608
- Mercy San Juan Medical Center
-
Carmichael, California, Estados Unidos, 95608
- Mercy Cancer Center - Carmichael
-
Castro Valley, California, Estados Unidos, 94546
- Eden Hospital Medical Center
-
Davis, California, Estados Unidos, 95616
- Sutter Davis Hospital
-
Elk Grove, California, Estados Unidos, 95758
- Mercy Cancer Center - Elk Grove
-
Fontana, California, Estados Unidos, 92335
- Kaiser Permanente-Fontana
-
Fremont, California, Estados Unidos, 94538
- Palo Alto Medical Foundation-Fremont
-
Harbor City, California, Estados Unidos, 90710
- Kaiser Permanente South Bay
-
Irvine, California, Estados Unidos, 92618
- Kaiser Permanente-Irvine
-
Los Angeles, California, Estados Unidos, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, Estados Unidos, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Los Angeles, California, Estados Unidos, 90034
- Kaiser Permanente West Los Angeles
-
Modesto, California, Estados Unidos, 95355
- Memorial Medical Center
-
Mountain View, California, Estados Unidos, 94040
- Palo Alto Medical Foundation-Camino Division
-
Mountain View, California, Estados Unidos, 94040
- Palo Alto Medical Foundation-Gynecologic Oncology
-
Napa, California, Estados Unidos, 94558
- Providence Queen of The Valley
-
Novato, California, Estados Unidos, 94945
- Sutter Cancer Research Consortium
-
Ontario, California, Estados Unidos, 91761
- Kaiser Permanente-Ontario
-
Palo Alto, California, Estados Unidos, 94301
- Palo Alto Medical Foundation Health Care
-
Panorama City, California, Estados Unidos, 91402
- Kaiser Permanente - Panorama City
-
Riverside, California, Estados Unidos, 92505
- Kaiser Permanente-Riverside
-
Rocklin, California, Estados Unidos, 95765
- Mercy Cancer Center - Rocklin
-
Roseville, California, Estados Unidos, 95661
- Sutter Cancer Centers Radiation Oncology Services-Roseville
-
Roseville, California, Estados Unidos, 95661
- Sutter Roseville Medical Center
-
Sacramento, California, Estados Unidos, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, Estados Unidos, 95816
- Mercy Cancer Center - Sacramento
-
San Diego, California, Estados Unidos, 92120
- Kaiser Permanente-San Diego Zion
-
San Diego, California, Estados Unidos, 92108
- Kaiser Permanente-Rio San Diego
-
San Francisco, California, Estados Unidos, 94115
- California Pacific Medical Center-Pacific Campus
-
San Luis Obispo, California, Estados Unidos, 93401
- Pacific Central Coast Health Center-San Luis Obispo
-
San Marcos, California, Estados Unidos, 92078
- Kaiser Permanente-San Marcos
-
Santa Cruz, California, Estados Unidos, 95065
- Palo Alto Medical Foundation-Santa Cruz
-
Santa Maria, California, Estados Unidos, 93444
- Mission Hope Medical Oncology - Santa Maria
-
Santa Rosa, California, Estados Unidos, 95403
- Sutter Pacific Medical Foundation
-
Santa Rosa, California, Estados Unidos, 95403
- Providence Medical Foundation - Santa Rosa
-
Santa Rosa, California, Estados Unidos, 95405
- Providence Santa Rosa Memorial Hospital
-
Sunnyvale, California, Estados Unidos, 94086
- Palo Alto Medical Foundation-Sunnyvale
-
Torrance, California, Estados Unidos, 90505
- Torrance Memorial Physician Network - Cancer Care
-
Vallejo, California, Estados Unidos, 94589
- Sutter Solano Medical Center/Cancer Center
-
Woodland, California, Estados Unidos, 95695
- Woodland Memorial Hospital
-
Woodland Hills, California, Estados Unidos, 91367
- Kaiser Permanente-Woodland Hills
-
-
Colorado
-
Aurora, Colorado, Estados Unidos, 80012
- Rocky Mountain Cancer Centers-Aurora
-
Aurora, Colorado, Estados Unidos, 80012
- The Medical Center of Aurora
-
Aurora, Colorado, Estados Unidos, 80045
- UCHealth University of Colorado Hospital
-
Boulder, Colorado, Estados Unidos, 80303
- Boulder Community Foothills Hospital
-
Boulder, Colorado, Estados Unidos, 80304
- Rocky Mountain Cancer Centers-Boulder
-
Centennial, Colorado, Estados Unidos, 80112
- Rocky Mountain Cancer Centers - Centennial
-
Colorado Springs, Colorado, Estados Unidos, 80907
- Penrose-Saint Francis Healthcare
-
Colorado Springs, Colorado, Estados Unidos, 80909
- UCHealth Memorial Hospital Central
-
Colorado Springs, Colorado, Estados Unidos, 80907
- Rocky Mountain Cancer Centers-Penrose
-
Colorado Springs, Colorado, Estados Unidos, 80920
- Memorial Hospital North
-
Colorado Springs, Colorado, Estados Unidos, 80923
- Saint Francis Cancer Center
-
Denver, Colorado, Estados Unidos, 80218
- Presbyterian - Saint Lukes Medical Center - Health One
-
Denver, Colorado, Estados Unidos, 80220
- Rose Medical Center
-
Denver, Colorado, Estados Unidos, 80218
- Rocky Mountain Cancer Centers-Midtown
-
Denver, Colorado, Estados Unidos, 80220
- Rocky Mountain Cancer Centers-Rose
-
Denver, Colorado, Estados Unidos, 80204
- Denver Health Medical Center
-
Denver, Colorado, Estados Unidos, 80218
- Colorado Blood Cancer Institute
-
Denver, Colorado, Estados Unidos, 80209
- The Women's Imaging Center
-
Denver, Colorado, Estados Unidos, 80206
- National Jewish Health-Main Campus
-
Denver, Colorado, Estados Unidos, 80220
- Western Surgical Care
-
Denver, Colorado, Estados Unidos, 80218
- Saint Joseph Hospital - Cancer Centers of Colorado
-
Denver, Colorado, Estados Unidos, 80210
- AdventHealth Porter
-
Durango, Colorado, Estados Unidos, 81301
- Mercy Medical Center
-
Durango, Colorado, Estados Unidos, 81301
- CommonSpirit Cancer Center Mercy
-
Englewood, Colorado, Estados Unidos, 80113
- Mountain Blue Cancer Care Center - Swedish
-
Englewood, Colorado, Estados Unidos, 80113
- Swedish Medical Center
-
Englewood, Colorado, Estados Unidos, 80113
- Rocky Mountain Cancer Centers - Swedish
-
Englewood, Colorado, Estados Unidos, 80113
- The Melanoma and Skin Cancer Institute
-
Fort Collins, Colorado, Estados Unidos, 80524
- Poudre Valley Hospital
-
Fort Collins, Colorado, Estados Unidos, 80528
- Cancer Care and Hematology-Fort Collins
-
Golden, Colorado, Estados Unidos, 80401
- Mountain Blue Cancer Care Center
-
Golden, Colorado, Estados Unidos, 80401
- National Jewish Health-Western Hematology Oncology
-
Grand Junction, Colorado, Estados Unidos, 81501
- Saint Mary's Hospital and Regional Medical Center
-
Greeley, Colorado, Estados Unidos, 80631
- UCHealth Greeley Hospital
-
Greeley, Colorado, Estados Unidos, 80631
- Banner North Colorado Medical Center
-
Lafayette, Colorado, Estados Unidos, 80026
- Good Samaritan Hospital - Cancer Centers of Colorado
-
Lakewood, Colorado, Estados Unidos, 80228
- Rocky Mountain Cancer Centers-Lakewood
-
Lakewood, Colorado, Estados Unidos, 80228
- CommonSpirit Saint Anthony Hospital Cancer Center
-
Littleton, Colorado, Estados Unidos, 80120
- Rocky Mountain Cancer Centers-Littleton
-
Littleton, Colorado, Estados Unidos, 80122
- AdventHealth Littleton
-
Lone Tree, Colorado, Estados Unidos, 80124
- Sky Ridge Medical Center
-
Lone Tree, Colorado, Estados Unidos, 80124
- Rocky Mountain Cancer Centers-Sky Ridge
-
Longmont, Colorado, Estados Unidos, 80501
- Longmont United Hospital
-
Longmont, Colorado, Estados Unidos, 80501
- Rocky Mountain Cancer Centers-Longmont
-
Loveland, Colorado, Estados Unidos, 80538
- Medical Center of the Rockies
-
Loveland, Colorado, Estados Unidos, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
Parker, Colorado, Estados Unidos, 80138
- Rocky Mountain Cancer Centers-Parker
-
Parker, Colorado, Estados Unidos, 80138
- AdventHealth Parker
-
Pueblo, Colorado, Estados Unidos, 81004
- Saint Mary Corwin Medical Center
-
Pueblo, Colorado, Estados Unidos, 81008
- Rocky Mountain Cancer Centers - Pueblo
-
Thornton, Colorado, Estados Unidos, 80260
- Rocky Mountain Cancer Centers-Thornton
-
Thornton, Colorado, Estados Unidos, 80260
- National Jewish Health-Northern Hematology Oncology
-
Wheat Ridge, Colorado, Estados Unidos, 80401
- Intermountain Health Lutheran Hospital
-
-
Connecticut
-
Derby, Connecticut, Estados Unidos, 06418
- Smilow Cancer Hospital-Derby Care Center
-
Fairfield, Connecticut, Estados Unidos, 06824
- Smilow Cancer Hospital Care Center-Fairfield
-
Guilford, Connecticut, Estados Unidos, 06437
- Smilow Cancer Hospital Care Center - Guilford
-
Hartford, Connecticut, Estados Unidos, 06105
- Smilow Cancer Hospital Care Center at Saint Francis
-
Hartford, Connecticut, Estados Unidos, 06102
- Hartford Hospital
-
New Britain, Connecticut, Estados Unidos, 06050
- The Hospital of Central Connecticut
-
New Haven, Connecticut, Estados Unidos, 06520
- Yale University
-
New Haven, Connecticut, Estados Unidos, 06510
- Smilow Cancer Center/Yale-New Haven Hospital
-
North Haven, Connecticut, Estados Unidos, 06473
- Yale-New Haven Hospital North Haven Medical Center
-
Torrington, Connecticut, Estados Unidos, 06790
- Smilow Cancer Hospital-Torrington Care Center
-
Trumbull, Connecticut, Estados Unidos, 06611
- Smilow Cancer Hospital Care Center-Trumbull
-
Waterbury, Connecticut, Estados Unidos, 06708
- Smilow Cancer Hospital-Waterbury Care Center
-
Waterford, Connecticut, Estados Unidos, 06385
- Smilow Cancer Hospital Care Center - Waterford
-
-
Delaware
-
Lewes, Delaware, Estados Unidos, 19958
- Beebe Medical Center
-
Millville, Delaware, Estados Unidos, 19967
- Beebe South Coastal Health Campus
-
Newark, Delaware, Estados Unidos, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Estados Unidos, 19713
- Delaware Clinical and Laboratory Physicians PA
-
Newark, Delaware, Estados Unidos, 19713
- Medical Oncology Hematology Consultants PA
-
Newark, Delaware, Estados Unidos, 19718
- Christiana Care Health System-Christiana Hospital
-
Rehoboth Beach, Delaware, Estados Unidos, 19971
- Beebe Health Campus
-
Seaford, Delaware, Estados Unidos, 19973
- TidalHealth Nanticoke / Allen Cancer Center
-
Wilmington, Delaware, Estados Unidos, 19801
- Christiana Care Health System-Wilmington Hospital
-
-
District of Columbia
-
Washington D.C., District of Columbia, Estados Unidos, 20037
- George Washington University Medical Center
-
Washington D.C., District of Columbia, Estados Unidos, 20016
- Sibley Memorial Hospital
-
-
Florida
-
Bradenton, Florida, Estados Unidos, 34205
- Florida Cancer Specialists - Bradenton Cancer Center
-
Gainesville, Florida, Estados Unidos, 32610
- UF Health Cancer Institute - Gainesville
-
Jupiter, Florida, Estados Unidos, 33458
- Jupiter Medical Center
-
Pensacola, Florida, Estados Unidos, 32504
- Sacred Heart Hospital
-
Sarasota, Florida, Estados Unidos, 34239
- Sarasota Memorial Hospital
-
Sarasota, Florida, Estados Unidos, 34232
- Florida Cancer Specialists - Sarasota
-
Sarasota, Florida, Estados Unidos, 34239
- Florida Cancer Specialists - Sarasota Downtown
-
Venice, Florida, Estados Unidos, 34285
- Florida Cancer Specialists - Venice Island
-
Venice, Florida, Estados Unidos, 34275
- Florida Cancer Specialists - Venice Pinebrook
-
-
Georgia
-
Atlanta, Georgia, Estados Unidos, 30308
- Emory University Hospital Midtown
-
Atlanta, Georgia, Estados Unidos, 30322
- Emory University Hospital/Winship Cancer Institute
-
Atlanta, Georgia, Estados Unidos, 30342
- Emory Saint Joseph's Hospital
-
Atlanta, Georgia, Estados Unidos, 30303
- Grady Health System
-
Atlanta, Georgia, Estados Unidos, 30309
- Piedmont Hospital
-
Fayetteville, Georgia, Estados Unidos, 30214
- Piedmont Fayette Hospital
-
Newnan, Georgia, Estados Unidos, 30265
- CTCA at Southeastern Regional Medical Center
-
Savannah, Georgia, Estados Unidos, 31405
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
Savannah, Georgia, Estados Unidos, 31404
- Memorial Health University Medical Center
-
Savannah, Georgia, Estados Unidos, 31404
- Summit Cancer Care-Memorial
-
Savannah, Georgia, Estados Unidos, 31405
- Summit Cancer Care-Candler
-
-
Hawaii
-
Honolulu, Hawaii, Estados Unidos, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Estados Unidos, 96817
- The Cancer Center of Hawaii-Liliha
-
Honolulu, Hawaii, Estados Unidos, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, Estados Unidos, 96813
- Queen's Cancer Cenrer - POB I
-
Honolulu, Hawaii, Estados Unidos, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Estados Unidos, 96813
- University of Hawaii Cancer Center
-
Honolulu, Hawaii, Estados Unidos, 96817
- Hawaii Cancer Care Inc-Liliha
-
Honolulu, Hawaii, Estados Unidos, 96817
- Kuakini Medical Center
-
Honolulu, Hawaii, Estados Unidos, 96817
- Queen's Cancer Center - Kuakini
-
Honolulu, Hawaii, Estados Unidos, 96826
- Kapiolani Medical Center for Women and Children
-
Honolulu, Hawaii, Estados Unidos, 96813
- Island Urology
-
Lihue, Hawaii, Estados Unidos, 96766
- Wilcox Memorial Hospital and Kauai Medical Clinic
-
‘Aiea, Hawaii, Estados Unidos, 96701
- Hawaii Cancer Care - Westridge
-
‘Aiea, Hawaii, Estados Unidos, 96701
- Pali Momi Medical Center
-
‘Aiea, Hawaii, Estados Unidos, 96701
- Queen's Cancer Center - Pearlridge
-
‘Aiea, Hawaii, Estados Unidos, 96701
- The Cancer Center of Hawaii-Pali Momi
-
-
Idaho
-
Boise, Idaho, Estados Unidos, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Boise, Idaho, Estados Unidos, 83712
- Saint Luke's Cancer Institute - Boise
-
Caldwell, Idaho, Estados Unidos, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Coeur d'Alene, Idaho, Estados Unidos, 83814
- Kootenai Health - Coeur d'Alene
-
Emmett, Idaho, Estados Unidos, 83617
- Walter Knox Memorial Hospital
-
Fruitland, Idaho, Estados Unidos, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, Estados Unidos, 83642
- Idaho Urologic Institute-Meridian
-
Meridian, Idaho, Estados Unidos, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, Estados Unidos, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
Nampa, Idaho, Estados Unidos, 83687
- Saint Luke's Cancer Institute - Nampa
-
Post Falls, Idaho, Estados Unidos, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
Sandpoint, Idaho, Estados Unidos, 83864
- Kootenai Clinic Cancer Services - Sandpoint
-
Twin Falls, Idaho, Estados Unidos, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Alton, Illinois, Estados Unidos, 62002
- OSF Saint Anthony's Health Center
-
Aurora, Illinois, Estados Unidos, 60504
- Rush-Copley Medical Center
-
Barrington, Illinois, Estados Unidos, 60010
- Advocate Good Shepherd Hospital
-
Bloomington, Illinois, Estados Unidos, 61704
- Illinois CancerCare-Bloomington
-
Bloomington, Illinois, Estados Unidos, 61704
- Carle BroMenn Outpatient Center
-
Canton, Illinois, Estados Unidos, 61520
- Illinois CancerCare-Canton
-
Carbondale, Illinois, Estados Unidos, 62902
- Memorial Hospital of Carbondale
-
Carterville, Illinois, Estados Unidos, 62918
- SIH Cancer Institute
-
Carthage, Illinois, Estados Unidos, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, Estados Unidos, 62801
- Centralia Oncology Clinic
-
Centralia, Illinois, Estados Unidos, 62801
- Saint Mary's Hospital
-
Chicago, Illinois, Estados Unidos, 60611
- Northwestern University
-
Chicago, Illinois, Estados Unidos, 60637
- University of Chicago Comprehensive Cancer Center
-
Chicago, Illinois, Estados Unidos, 60612
- John H Stroger Jr Hospital of Cook County
-
Chicago, Illinois, Estados Unidos, 60657
- Advocate Illinois Masonic Medical Center
-
Chicago, Illinois, Estados Unidos, 60612
- Rush MD Anderson Cancer Center
-
Crystal Lake, Illinois, Estados Unidos, 60014
- AMG Crystal Lake - Oncology
-
Danville, Illinois, Estados Unidos, 61832
- Carle at The Riverfront
-
Decatur, Illinois, Estados Unidos, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Estados Unidos, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Dixon, Illinois, Estados Unidos, 61021
- Illinois CancerCare-Dixon
-
Downers Grove, Illinois, Estados Unidos, 60515
- Advocate Good Samaritan Hospital
-
Effingham, Illinois, Estados Unidos, 62401
- Crossroads Cancer Center
-
Effingham, Illinois, Estados Unidos, 62401
- Carle Physician Group-Effingham
-
Elgin, Illinois, Estados Unidos, 60123
- Advocate Sherman Hospital
-
Eureka, Illinois, Estados Unidos, 61530
- Illinois CancerCare-Eureka
-
Evanston, Illinois, Estados Unidos, 60201
- NorthShore University HealthSystem-Evanston Hospital
-
Galesburg, Illinois, Estados Unidos, 61401
- Western Illinois Cancer Treatment Center
-
Galesburg, Illinois, Estados Unidos, 61401
- Illinois CancerCare-Galesburg
-
Geneva, Illinois, Estados Unidos, 60134
- Northwestern Medicine Cancer Center Delnor
-
Glenview, Illinois, Estados Unidos, 60026
- NorthShore University HealthSystem-Glenbrook Hospital
-
Harvey, Illinois, Estados Unidos, 60426
- Ingalls Memorial Hospital
-
Hazel Crest, Illinois, Estados Unidos, 60429
- Advocate South Suburban Hospital
-
Highland Park, Illinois, Estados Unidos, 60035
- NorthShore University HealthSystem-Highland Park Hospital
-
Hinsdale, Illinois, Estados Unidos, 60521
- Sudarshan K Sharma MD Limited-Gynecologic Oncology
-
Kewanee, Illinois, Estados Unidos, 61443
- Illinois CancerCare-Kewanee Clinic
-
Lake Forest, Illinois, Estados Unidos, 60045
- Northwestern Medicine Lake Forest Hospital
-
Macomb, Illinois, Estados Unidos, 61455
- Illinois CancerCare-Macomb
-
Mattoon, Illinois, Estados Unidos, 61938
- Carle Physician Group-Mattoon/Charleston
-
Mount Vernon, Illinois, Estados Unidos, 62864
- SSM Health Good Samaritan
-
New Lenox, Illinois, Estados Unidos, 60451
- UC Comprehensive Cancer Center at Silver Cross
-
Normal, Illinois, Estados Unidos, 61761
- Carle Cancer Institute Normal
-
Normal, Illinois, Estados Unidos, 61761
- Carle BroMenn Medical Center
-
O'Fallon, Illinois, Estados Unidos, 62269
- Cancer Care Center of O'Fallon
-
Oak Lawn, Illinois, Estados Unidos, 60453-2699
- Advocate Christ Medical Center
-
Orland Park, Illinois, Estados Unidos, 60462
- University of Chicago Medicine-Orland Park
-
Ottawa, Illinois, Estados Unidos, 61350
- Illinois CancerCare-Ottawa Clinic
-
Park Ridge, Illinois, Estados Unidos, 60068
- Advocate Lutheran General Hospital
-
Pekin, Illinois, Estados Unidos, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Estados Unidos, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Estados Unidos, 61615
- Illinois CancerCare-Peoria
-
Peru, Illinois, Estados Unidos, 61354
- Illinois CancerCare-Peru
-
Peru, Illinois, Estados Unidos, 61354
- Valley Radiation Oncology
-
Princeton, Illinois, Estados Unidos, 61356
- Illinois CancerCare-Princeton
-
Springfield, Illinois, Estados Unidos, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Estados Unidos, 62702
- Springfield Clinic
-
Springfield, Illinois, Estados Unidos, 62781
- Springfield Memorial Hospital
-
Swansea, Illinois, Estados Unidos, 62226
- Southwest Illinois Health Services LLP
-
Urbana, Illinois, Estados Unidos, 61801
- Carle Cancer Center
-
Urbana, Illinois, Estados Unidos, 61801
- The Carle Foundation Hospital
-
Warrenville, Illinois, Estados Unidos, 60555
- Northwestern Medicine Cancer Center Warrenville
-
Washington, Illinois, Estados Unidos, 61571
- Illinois CancerCare - Washington
-
Yorkville, Illinois, Estados Unidos, 60560
- Rush-Copley Healthcare Center
-
Zion, Illinois, Estados Unidos, 60099
- Midwestern Regional Medical Center
-
-
Indiana
-
Crown Point, Indiana, Estados Unidos, 46307
- Northwest Cancer Center - Crown Point
-
Dyer, Indiana, Estados Unidos, 46311
- Northwest Oncology LLC
-
Fort Wayne, Indiana, Estados Unidos, 46805
- Parkview Hospital Randallia
-
Fort Wayne, Indiana, Estados Unidos, 46845
- Parkview Regional Medical Center
-
Hobart, Indiana, Estados Unidos, 46342
- Northwest Cancer Center - Hobart
-
Hobart, Indiana, Estados Unidos, 46342
- Saint Mary Medical Center
-
Indianapolis, Indiana, Estados Unidos, 46202
- Indiana University/Melvin and Bren Simon Cancer Center
-
Indianapolis, Indiana, Estados Unidos, 46260
- Ascension Saint Vincent Indianapolis Hospital
-
Indianapolis, Indiana, Estados Unidos, 46202
- Sidney and Lois Eskenazi Hospital
-
Indianapolis, Indiana, Estados Unidos, 46312
- Saint Catherine Hospital
-
Munster, Indiana, Estados Unidos, 46321
- The Community Hospital
-
Munster, Indiana, Estados Unidos, 46321
- Women's Diagnostic Center - Munster
-
Richmond, Indiana, Estados Unidos, 47374
- Reid Health
-
South Bend, Indiana, Estados Unidos, 46601
- Memorial Hospital of South Bend
-
Valparaiso, Indiana, Estados Unidos, 46383
- Northwest Cancer Center - Valparaiso
-
-
Iowa
-
Clive, Iowa, Estados Unidos, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Estados Unidos, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Council Bluffs, Iowa, Estados Unidos, 51503
- Alegent Health Mercy Hospital
-
Creston, Iowa, Estados Unidos, 50801
- Greater Regional Medical Center
-
Des Moines, Iowa, Estados Unidos, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Estados Unidos, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Estados Unidos, 50314
- Broadlawns Medical Center
-
Des Moines, Iowa, Estados Unidos, 50316
- Iowa Lutheran Hospital
-
Des Moines, Iowa, Estados Unidos, 50309
- UI Health Care Mission Cancer and Blood - Des Moines Clinic
-
Des Moines, Iowa, Estados Unidos, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
Fort Dodge, Iowa, Estados Unidos, 50501
- UI Healthcare Mission Cancer and Blood - Fort Dodge
-
Iowa City, Iowa, Estados Unidos, 52242
- University of Iowa/Holden Comprehensive Cancer Center
-
West Des Moines, Iowa, Estados Unidos, 50266-7700
- Methodist West Hospital
-
West Des Moines, Iowa, Estados Unidos, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Garden City, Kansas, Estados Unidos, 67846
- Central Care Cancer Center - Garden City
-
Great Bend, Kansas, Estados Unidos, 67530
- Central Care Cancer Center - Great Bend
-
Wichita, Kansas, Estados Unidos, 67214
- Ascension Via Christi Hospitals Wichita
-
Wichita, Kansas, Estados Unidos, 67208
- Cancer Center of Kansas-Wichita Medical Arts Tower
-
Wichita, Kansas, Estados Unidos, 67214
- Cancer Center of Kansas - Wichita
-
Wichita, Kansas, Estados Unidos, 67208
- Associates In Womens Health
-
-
Kentucky
-
Bardstown, Kentucky, Estados Unidos, 40004
- CommonSpirit Saint Joseph Hospital - Bardstown
-
Corbin, Kentucky, Estados Unidos, 40701
- Baptist Health Corbin
-
Corbin, Kentucky, Estados Unidos, 40701
- Commonwealth Cancer Center-Corbin
-
Edgewood, Kentucky, Estados Unidos, 41017
- Saint Elizabeth Healthcare Edgewood
-
Lexington, Kentucky, Estados Unidos, 40504
- Saint Joseph Radiation Oncology Resource Center
-
Lexington, Kentucky, Estados Unidos, 40503
- Baptist Health Lexington
-
Lexington, Kentucky, Estados Unidos, 40509
- CommonSpirit Saint Joseph Medical Center - East Lexington
-
Lexington, Kentucky, Estados Unidos, 40504
- CommonSpirit Saint Joseph Hospital - Lexington
-
London, Kentucky, Estados Unidos, 40741
- CommonSpirit Saint Joseph Hospital London
-
Louisville, Kentucky, Estados Unidos, 40202
- Jewish Hospital
-
Louisville, Kentucky, Estados Unidos, 40245
- UofL Health Medical Center Northeast
-
Louisville, Kentucky, Estados Unidos, 40207
- Baptist Health Louisville
-
Louisville, Kentucky, Estados Unidos, 40215
- Saints Mary and Elizabeth Hospital
-
Madisonville, Kentucky, Estados Unidos, 42431
- Baptist Health Madisonville/Merle Mahr Cancer Center
-
Mount Sterling, Kentucky, Estados Unidos, 40353
- CommonSpirit Saint Joseph Hospital Mount Sterling
-
Paducah, Kentucky, Estados Unidos, 42003
- Baptist Health Paducah
-
Paducah, Kentucky, Estados Unidos, 42003
- Mercy Health - Paducah Cancer Center
-
Richmond, Kentucky, Estados Unidos, 40475
- Baptist Health Richmond
-
Shepherdsville, Kentucky, Estados Unidos, 40165
- Jewish Hospital Medical Center South
-
-
Louisiana
-
Baton Rouge, Louisiana, Estados Unidos, 70809
- Mary Bird Perkins Cancer Center
-
Covington, Louisiana, Estados Unidos, 70433
- Women's Cancer Care-Covington
-
New Orleans, Louisiana, Estados Unidos, 70121
- Ochsner Medical Center Jefferson
-
New Orleans, Louisiana, Estados Unidos, 70115
- Ochsner Baptist Medical Center
-
-
Maine
-
Bangor, Maine, Estados Unidos, 04401
- Eastern Maine Medical Center
-
Brewer, Maine, Estados Unidos, 04412
- Lafayette Family Cancer Center-EMMC
-
Scarborough, Maine, Estados Unidos, 04074
- MaineHealth Maine Medical Center- Scarborough
-
-
Maryland
-
Annapolis, Maryland, Estados Unidos, 21401
- Luminis Health Anne Arundel Medical Center
-
Baltimore, Maryland, Estados Unidos, 21287
- Johns Hopkins University/Sidney Kimmel Cancer Center
-
Baltimore, Maryland, Estados Unidos, 21204
- Greater Baltimore Medical Center
-
Bethesda, Maryland, Estados Unidos, 20889-5600
- Walter Reed National Military Medical Center
-
Easton, Maryland, Estados Unidos, 21601
- University of Maryland Shore Medical Center at Easton
-
Elkton, Maryland, Estados Unidos, 21921
- Christiana Care - Union Hospital
-
-
Massachusetts
-
Beverly, Massachusetts, Estados Unidos, 01915
- Beverly Hospital
-
Burlington, Massachusetts, Estados Unidos, 01805
- Lahey Clinic
-
Gloucester, Massachusetts, Estados Unidos, 01930
- Addison Gilbert Hospital
-
Peabody, Massachusetts, Estados Unidos, 01960
- Lahey Clinic Peabody
-
Springfield, Massachusetts, Estados Unidos, 01199
- Baystate Medical Center
-
Winchester, Massachusetts, Estados Unidos, 01890
- Beth Israel Deaconess Medical Center/Winchester Center for Cancer Care
-
Worcester, Massachusetts, Estados Unidos, 01605
- UMass Memorial Medical Center - Memorial Division
-
-
Michigan
-
Ann Arbor, Michigan, Estados Unidos, 48109
- University of Michigan Rogel Cancer Center
-
Brighton, Michigan, Estados Unidos, 48116
- University of Michigan - Brighton Center for Specialty Care
-
Detroit, Michigan, Estados Unidos, 48201
- Wayne State University/Karmanos Cancer Institute
-
Farmington Hills, Michigan, Estados Unidos, 48334
- Weisberg Cancer Treatment Center
-
Port Huron, Michigan, Estados Unidos, 48060
- Lake Huron Medical Center
-
Port Huron, Michigan, Estados Unidos, 48060
- Huron Medical Center PC
-
-
Minnesota
-
Aitkin, Minnesota, Estados Unidos, 56431
- Riverwood Healthcare Center
-
Baxter, Minnesota, Estados Unidos, 56425
- Essentia Health - Baxter Clinic
-
Bemidji, Minnesota, Estados Unidos, 56601
- Sanford Joe Lueken Cancer Center
-
Brainerd, Minnesota, Estados Unidos, 56401
- Essentia Health Saint Joseph's Medical Center
-
Burnsville, Minnesota, Estados Unidos, 55337
- Fairview Ridges Hospital
-
Burnsville, Minnesota, Estados Unidos, 55337
- Minnesota Oncology - Burnsville
-
Cambridge, Minnesota, Estados Unidos, 55008
- Cambridge Medical Center
-
Coon Rapids, Minnesota, Estados Unidos, 55433
- Mercy Hospital
-
Deer River, Minnesota, Estados Unidos, 56636
- Essentia Health - Deer River Clinic
-
Detroit Lakes, Minnesota, Estados Unidos, 56501
- Essentia Health Saint Mary's - Detroit Lakes Clinic
-
Duluth, Minnesota, Estados Unidos, 55805
- Essentia Health Cancer Center
-
Duluth, Minnesota, Estados Unidos, 55805
- Essentia Health Saint Mary's Medical Center
-
Duluth, Minnesota, Estados Unidos, 55805
- Miller-Dwan Hospital
-
Edina, Minnesota, Estados Unidos, 55435
- Fairview Southdale Hospital
-
Ely, Minnesota, Estados Unidos, 55731
- Essentia Health - Ely Clinic
-
Fergus Falls, Minnesota, Estados Unidos, 56537
- Lake Region Healthcare Corporation-Cancer Care
-
Fosston, Minnesota, Estados Unidos, 56542
- Essentia Health - Fosston
-
Fridley, Minnesota, Estados Unidos, 55432
- Unity Hospital
-
Hibbing, Minnesota, Estados Unidos, 55746
- Essentia Health Hibbing Clinic
-
International Falls, Minnesota, Estados Unidos, 56649
- Essentia Health - International Falls Clinic
-
Maple Grove, Minnesota, Estados Unidos, 55369
- Fairview Clinics and Surgery Center Maple Grove
-
Maplewood, Minnesota, Estados Unidos, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Estados Unidos, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Estados Unidos, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Estados Unidos, 55407
- Abbott-Northwestern Hospital
-
Minneapolis, Minnesota, Estados Unidos, 55454
- Health Partners Inc
-
Monticello, Minnesota, Estados Unidos, 55362
- Monticello Cancer Center
-
Moose Lake, Minnesota, Estados Unidos, 55767
- Essentia Health - Moose Lake Clinic
-
New Ulm, Minnesota, Estados Unidos, 56073
- New Ulm Medical Center
-
Park Rapids, Minnesota, Estados Unidos, 56470
- Essentia Health - Park Rapids
-
Princeton, Minnesota, Estados Unidos, 55371
- Fairview Northland Medical Center
-
Robbinsdale, Minnesota, Estados Unidos, 55422
- North Memorial Medical Health Center
-
Rochester, Minnesota, Estados Unidos, 55905
- Mayo Clinic in Rochester
-
Saint Louis Park, Minnesota, Estados Unidos, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, Estados Unidos, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Estados Unidos, 55102
- United Hospital
-
Sandstone, Minnesota, Estados Unidos, 55072
- Essentia Health Sandstone
-
Shakopee, Minnesota, Estados Unidos, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, Estados Unidos, 55082
- Lakeview Hospital
-
Thief River Falls, Minnesota, Estados Unidos, 56701
- Sanford Thief River Falls Medical Center
-
Virginia, Minnesota, Estados Unidos, 55792
- Essentia Health Virginia Clinic
-
Waconia, Minnesota, Estados Unidos, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Estados Unidos, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, Estados Unidos, 55125
- Minnesota Oncology Hematology PA-Woodbury
-
Worthington, Minnesota, Estados Unidos, 56187
- Sanford Cancer Center Worthington
-
Wyoming, Minnesota, Estados Unidos, 55092
- Fairview Lakes Medical Center
-
-
Mississippi
-
Jackson, Mississippi, Estados Unidos, 39216
- University of Mississippi Medical Center
-
-
Missouri
-
Ballwin, Missouri, Estados Unidos, 63011
- Mercy Oncology and Hematology - Clayton-Clarkson
-
Bolivar, Missouri, Estados Unidos, 65613
- Central Care Cancer Center - Bolivar
-
Bonne Terre, Missouri, Estados Unidos, 63628
- Parkland Health Center-Bonne Terre
-
Branson, Missouri, Estados Unidos, 65616
- Cox Cancer Center Branson
-
Cape Girardeau, Missouri, Estados Unidos, 63703
- Saint Francis Medical Center
-
Cape Girardeau, Missouri, Estados Unidos, 63703
- Mercy Cancer Center - Cape Girardeau
-
Columbia, Missouri, Estados Unidos, 65212
- MU Health - University Hospital/Ellis Fischel Cancer Center
-
Farmington, Missouri, Estados Unidos, 63640
- Parkland Health Center - Farmington
-
Jefferson City, Missouri, Estados Unidos, 65109
- MU Health Care Goldschmidt Cancer Center
-
Joplin, Missouri, Estados Unidos, 64804
- Freeman Health System
-
Joplin, Missouri, Estados Unidos, 64804
- Mercy Hospital Joplin
-
Rolla, Missouri, Estados Unidos, 65401
- Mercy Clinic-Rolla-Cancer and Hematology
-
Rolla, Missouri, Estados Unidos, 65401
- Phelps Health Delbert Day Cancer Institute
-
Saint Joseph, Missouri, Estados Unidos, 64506
- Heartland Regional Medical Center
-
Sainte Genevieve, Missouri, Estados Unidos, 63670
- Sainte Genevieve County Memorial Hospital
-
Springfield, Missouri, Estados Unidos, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, Estados Unidos, 65804
- Mercy Hospital Springfield
-
St Louis, Missouri, Estados Unidos, 63110
- Washington University School of Medicine
-
St Louis, Missouri, Estados Unidos, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, Estados Unidos, 63109
- Mercy Infusion Center - Chippewa
-
St Louis, Missouri, Estados Unidos, 63141
- Mercy Hospital Saint Louis
-
St Louis, Missouri, Estados Unidos, 63128
- Mercy Hospital South
-
Sullivan, Missouri, Estados Unidos, 63080
- Missouri Baptist Sullivan Hospital
-
Washington, Missouri, Estados Unidos, 63090
- Mercy Hospital Washington
-
-
Montana
-
Anaconda, Montana, Estados Unidos, 59711
- Community Hospital of Anaconda
-
Billings, Montana, Estados Unidos, 59101
- Billings Clinic Cancer Center
-
Billings, Montana, Estados Unidos, 59101
- Saint Vincent Healthcare
-
Billings, Montana, Estados Unidos, 59102
- Saint Vincent Frontier Cancer Center
-
Bozeman, Montana, Estados Unidos, 59715
- Bozeman Health Deaconess Hospital
-
Butte, Montana, Estados Unidos, 59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, Estados Unidos, 59405
- Great Falls Clinic
-
Great Falls, Montana, Estados Unidos, 59405
- Benefis Sletten Cancer Institute
-
Helena, Montana, Estados Unidos, 59601
- Saint Peter's Community Hospital
-
Kalispell, Montana, Estados Unidos, 59901
- Logan Health Medical Center
-
Missoula, Montana, Estados Unidos, 59802
- Saint Patrick Hospital - Community Hospital
-
Missoula, Montana, Estados Unidos, 59804
- Community Medical Center
-
-
Nebraska
-
Grand Island, Nebraska, Estados Unidos, 68803
- Nebraska Cancer Specialists/Oncology Hematology West PC
-
Kearney, Nebraska, Estados Unidos, 68847
- CHI Health Good Samaritan
-
Kearney, Nebraska, Estados Unidos, 68845
- Fred and Pamela Buffett Cancer Center - Kearney
-
Lincoln, Nebraska, Estados Unidos, 68510
- Saint Elizabeth Regional Medical Center
-
Omaha, Nebraska, Estados Unidos, 68114
- Nebraska Methodist Hospital
-
Omaha, Nebraska, Estados Unidos, 68198
- University of Nebraska Medical Center
-
Omaha, Nebraska, Estados Unidos, 68124
- Alegent Health Bergan Mercy Medical Center
-
Omaha, Nebraska, Estados Unidos, 68118
- Nebraska Medicine-Village Pointe
-
Omaha, Nebraska, Estados Unidos, 68122
- Alegent Health Immanuel Medical Center
-
Omaha, Nebraska, Estados Unidos, 68130
- Alegent Health Lakeside Hospital
-
Omaha, Nebraska, Estados Unidos, 68122
- Hematology and Oncology Consultants PC
-
Omaha, Nebraska, Estados Unidos, 68114
- Oncology Associates PC
-
Omaha, Nebraska, Estados Unidos, 68114
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC
-
Papillion, Nebraska, Estados Unidos, 68046
- Midlands Community Hospital
-
-
Nevada
-
Carson City, Nevada, Estados Unidos, 89703
- Carson Tahoe Regional Medical Center
-
Henderson, Nevada, Estados Unidos, 89052
- Comprehensive Cancer Centers of Nevada - Henderson
-
Henderson, Nevada, Estados Unidos, 89052
- Cancer and Blood Specialists-Henderson
-
Henderson, Nevada, Estados Unidos, 89052
- Las Vegas Cancer Center-Henderson
-
Henderson, Nevada, Estados Unidos, 89074
- Comprehensive Cancer Centers of Nevada-Southeast Henderson
-
Henderson, Nevada, Estados Unidos, 89052
- Comprehensive Cancer Centers of Nevada-Horizon Ridge
-
Henderson, Nevada, Estados Unidos, 89074
- Las Vegas Urology - Green Valley
-
Henderson, Nevada, Estados Unidos, 89074
- Las Vegas Urology - Pebble
-
Henderson, Nevada, Estados Unidos, 89074
- Urology Specialists of Nevada - Green Valley
-
Henderson, Nevada, Estados Unidos, 89074
- Oncology Las Vegas - Henderson
-
Las Vegas, Nevada, Estados Unidos, 89144
- Summerlin Hospital Medical Center
-
Las Vegas, Nevada, Estados Unidos, 89109
- Sunrise Hospital and Medical Center
-
Las Vegas, Nevada, Estados Unidos, 89102
- OptumCare Cancer Care at Charleston
-
Las Vegas, Nevada, Estados Unidos, 89106
- Radiation Oncology Centers of Nevada Central
-
Las Vegas, Nevada, Estados Unidos, 89119
- Radiation Oncology Centers of Nevada Southeast
-
Las Vegas, Nevada, Estados Unidos, 89128
- Comprehensive Cancer Centers of Nevada - Northwest
-
Las Vegas, Nevada, Estados Unidos, 89128
- OptumCare Cancer Care at MountainView
-
Las Vegas, Nevada, Estados Unidos, 89135
- Alliance for Childhood Diseases/Cure 4 the Kids Foundation
-
Las Vegas, Nevada, Estados Unidos, 89144
- Comprehensive Cancer Centers of Nevada - Town Center
-
Las Vegas, Nevada, Estados Unidos, 89144
- Comprehensive Cancer Centers of Nevada-Summerlin
-
Las Vegas, Nevada, Estados Unidos, 89148
- Comprehensive Cancer Centers of Nevada
-
Las Vegas, Nevada, Estados Unidos, 89169
- Comprehensive Cancer Centers of Nevada - Central Valley
-
Las Vegas, Nevada, Estados Unidos, 89106
- Women's Cancer Center of Nevada
-
Las Vegas, Nevada, Estados Unidos, 89102
- University Medical Center of Southern Nevada
-
Las Vegas, Nevada, Estados Unidos, 89106
- Cancer and Blood Specialists-Shadow
-
Las Vegas, Nevada, Estados Unidos, 89109
- HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
-
Las Vegas, Nevada, Estados Unidos, 89113
- HealthCare Partners Medical Group Oncology/Hematology-San Martin
-
Las Vegas, Nevada, Estados Unidos, 89128
- Cancer and Blood Specialists-Tenaya
-
Las Vegas, Nevada, Estados Unidos, 89128
- HealthCare Partners Medical Group Oncology/Hematology-Tenaya
-
Las Vegas, Nevada, Estados Unidos, 89148-2405
- Las Vegas Cancer Center-Medical Center
-
Las Vegas, Nevada, Estados Unidos, 89149
- HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
-
Las Vegas, Nevada, Estados Unidos, 89128
- Ann M Wierman MD LTD
-
Las Vegas, Nevada, Estados Unidos, 89074
- Las Vegas Urology - Pecos
-
Las Vegas, Nevada, Estados Unidos, 89102
- Desert West Surgery
-
Las Vegas, Nevada, Estados Unidos, 89103
- Hope Cancer Care of Nevada
-
Las Vegas, Nevada, Estados Unidos, 89106
- Urology Specialists of Nevada - Central
-
Las Vegas, Nevada, Estados Unidos, 89113
- Las Vegas Prostate Cancer Center
-
Las Vegas, Nevada, Estados Unidos, 89113
- Las Vegas Urology - Sunset
-
Las Vegas, Nevada, Estados Unidos, 89128
- Las Vegas Urology - Cathedral Rock
-
Las Vegas, Nevada, Estados Unidos, 89128
- Las Vegas Urology - Smoke Ranch
-
Las Vegas, Nevada, Estados Unidos, 89128
- Urology Specialists of Nevada - Northwest
-
Las Vegas, Nevada, Estados Unidos, 89169
- University Cancer Center
-
Las Vegas, Nevada, Estados Unidos, 89113
- Urology Specialists of Nevada - Southwest
-
Las Vegas, Nevada, Estados Unidos, 89128
- Oncology Las Vegas - Tenaya
-
Las Vegas, Nevada, Estados Unidos, 89183
- OptumCare Cancer Care at Fort Apache
-
Pahrump, Nevada, Estados Unidos, 89048
- Hope Cancer Care of Nevada-Pahrump
-
Reno, Nevada, Estados Unidos, 89502
- Renown Regional Medical Center
-
Reno, Nevada, Estados Unidos, 89503
- Saint Mary's Regional Medical Center
-
Reno, Nevada, Estados Unidos, 89509
- Radiation Oncology Associates
-
-
New Hampshire
-
Lebanon, New Hampshire, Estados Unidos, 03756
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
Manchester, New Hampshire, Estados Unidos, 03104
- Dartmouth Cancer Center - Manchester/ DCC Manchester
-
Nashua, New Hampshire, Estados Unidos, 03063
- Dartmouth Cancer Center - Nashua
-
-
New Jersey
-
Mount Holly, New Jersey, Estados Unidos, 08060
- Virtua Memorial
-
Voorhees Township, New Jersey, Estados Unidos, 08043
- Virtua Voorhees
-
-
New Mexico
-
Albuquerque, New Mexico, Estados Unidos, 87106
- Southwest Gynecologic Oncology Associates Inc
-
Albuquerque, New Mexico, Estados Unidos, 87106
- University of New Mexico Cancer Center
-
Rio Rancho, New Mexico, Estados Unidos, 87124
- Presbyterian Rust Medical Center/Jorgensen Cancer Center
-
-
New York
-
Albany, New York, Estados Unidos, 12208
- Women's Cancer Care Associates LLC
-
Buffalo, New York, Estados Unidos, 14263
- Roswell Park Cancer Institute
-
New York, New York, Estados Unidos, 10029
- Mount Sinai Hospital
-
New York, New York, Estados Unidos, 10011
- Mount Sinai Chelsea
-
New York, New York, Estados Unidos, 10016
- Laura and Isaac Perlmutter Cancer Center at NYU Langone
-
Rochester, New York, Estados Unidos, 14642
- University of Rochester
-
The Bronx, New York, Estados Unidos, 10461
- Montefiore Medical Center-Einstein Campus
-
The Bronx, New York, Estados Unidos, 10467
- Montefiore Medical Center - Moses Campus
-
The Bronx, New York, Estados Unidos, 10461
- Montefiore Medical Center-Weiler Hospital
-
White Plains, New York, Estados Unidos, 10601
- Dickstein Cancer Treatment Center
-
-
North Carolina
-
Asheboro, North Carolina, Estados Unidos, 27203
- Randolph Hospital
-
Asheville, North Carolina, Estados Unidos, 28816
- Hope Women's Cancer Centers-Asheville
-
Burlington, North Carolina, Estados Unidos, 27215
- Cone Health Cancer Center at Alamance Regional
-
Cary, North Carolina, Estados Unidos, 27518
- Duke Cancer Center Cary
-
Chapel Hill, North Carolina, Estados Unidos, 27599
- UNC Lineberger Comprehensive Cancer Center
-
Charlotte, North Carolina, Estados Unidos, 28204
- Novant Health Presbyterian Medical Center
-
Charlotte, North Carolina, Estados Unidos, 28207
- Oncology Specialists of Charlotte
-
Charlotte, North Carolina, Estados Unidos, 28262
- Southern Oncology Specialists-Charlotte
-
Charlotte, North Carolina, Estados Unidos, 28207
- Novant Health Carolina Surgical - Randolph
-
Clinton, North Carolina, Estados Unidos, 28328
- Southeastern Medical Oncology Center-Clinton
-
Durham, North Carolina, Estados Unidos, 27710
- Duke University Medical Center
-
Goldsboro, North Carolina, Estados Unidos, 27534
- Southeastern Medical Oncology Center-Goldsboro
-
Goldsboro, North Carolina, Estados Unidos, 27534
- Wayne Memorial Hospital
-
Greensboro, North Carolina, Estados Unidos, 27403
- Cone Health Cancer Center
-
Huntersville, North Carolina, Estados Unidos, 28078
- Novant Health Cancer Institute - Huntersville
-
Huntersville, North Carolina, Estados Unidos, 28078
- Southern Oncology Specialists-Huntersville
-
Huntersville, North Carolina, Estados Unidos, 28078
- Novant Health Presbyterian Medical Center Huntersville
-
Jacksonville, North Carolina, Estados Unidos, 28546
- Southeastern Medical Oncology Center-Jacksonville
-
Jacksonville, North Carolina, Estados Unidos, 28546
- Onslow Memorial Hospital
-
Kernersville, North Carolina, Estados Unidos, 27284
- Novant Health Cancer Institute - Kernersville
-
Matthews, North Carolina, Estados Unidos, 28105
- Matthews Radiation Oncology Center
-
Matthews, North Carolina, Estados Unidos, 28105
- Novant Health Cancer Institute - Matthews
-
Mebane, North Carolina, Estados Unidos, 27302
- Cone Heath Cancer Center at Mebane
-
Mooresville, North Carolina, Estados Unidos, 28117
- Novant Health Cancer Institute - Mooresville
-
Mount Airy, North Carolina, Estados Unidos, 27030
- Novant Health Cancer Institute - Mount Airy
-
North Wilkesboro, North Carolina, Estados Unidos, 28659
- Novant Health Cancer Institute - Wilkesboro
-
Raleigh, North Carolina, Estados Unidos, 27607
- Duke Women's Cancer Care Raleigh
-
Raleigh, North Carolina, Estados Unidos, 27609
- Duke Cancer Center Raleigh
-
Reidsville, North Carolina, Estados Unidos, 27320
- Annie Penn Memorial Hospital
-
Salisbury, North Carolina, Estados Unidos, 28144
- Novant Health Cancer Institute - Rowan
-
Salisbury, North Carolina, Estados Unidos, 28144
- Rowan Regional Medical Center
-
Statesville, North Carolina, Estados Unidos, 28625
- Novant Health Cancer Institute - Statesville
-
Thomasville, North Carolina, Estados Unidos, 27360
- Novant Health Cancer Institute - Thomasville
-
Winston-Salem, North Carolina, Estados Unidos, 27103
- Novant Health Forsyth Medical Center
-
Winston-Salem, North Carolina, Estados Unidos, 27103
- Novant Health Oncology Specialists
-
-
North Dakota
-
Bismarck, North Dakota, Estados Unidos, 58501
- Sanford Bismarck Medical Center
-
Fargo, North Dakota, Estados Unidos, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, Estados Unidos, 58103
- Essentia Health Cancer Center-South University Clinic
-
Fargo, North Dakota, Estados Unidos, 58122
- Sanford Broadway Medical Center
-
Fargo, North Dakota, Estados Unidos, 58103
- Sanford South University Medical Center
-
Fargo, North Dakota, Estados Unidos, 58104
- Sanford Medical Center Fargo
-
Jamestown, North Dakota, Estados Unidos, 58401
- Essentia Health - Jamestown Clinic
-
-
Ohio
-
Akron, Ohio, Estados Unidos, 44304
- Summa Health System - Akron Campus
-
Alliance, Ohio, Estados Unidos, 44601
- Aultman Alliance Community Hospital
-
Beachwood, Ohio, Estados Unidos, 44122
- UHHS-Chagrin Highlands Medical Center
-
Beavercreek, Ohio, Estados Unidos, 45431
- Indu and Raj Soin Medical Center
-
Belpre, Ohio, Estados Unidos, 45714
- Strecker Cancer Center-Belpre
-
Boardman, Ohio, Estados Unidos, 44512
- Saint Elizabeth Boardman Hospital
-
Canton, Ohio, Estados Unidos, 44710
- Aultman Health Foundation
-
Centerville, Ohio, Estados Unidos, 45459
- Miami Valley Hospital South
-
Centerville, Ohio, Estados Unidos, 45459
- Dayton Physicians LLC-Miami Valley South
-
Chardon, Ohio, Estados Unidos, 44024
- Geauga Hospital
-
Chillicothe, Ohio, Estados Unidos, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, Estados Unidos, 45220
- Good Samaritan Hospital - Cincinnati
-
Cincinnati, Ohio, Estados Unidos, 45242
- Bethesda North Hospital
-
Cincinnati, Ohio, Estados Unidos, 45236
- Oncology Hematology Care Inc-Kenwood
-
Cincinnati, Ohio, Estados Unidos, 45247
- TriHealth Cancer Institute-Westside
-
Cincinnati, Ohio, Estados Unidos, 45255
- TriHealth Cancer Institute-Anderson
-
Cleveland, Ohio, Estados Unidos, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Estados Unidos, 44109
- MetroHealth Medical Center
-
Cleveland, Ohio, Estados Unidos, 44195
- Cleveland Clinic Foundation
-
Cleveland, Ohio, Estados Unidos, 44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus, Ohio, Estados Unidos, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, Estados Unidos, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, Estados Unidos, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Estados Unidos, 43214
- Columbus Oncology and Hematology Associates Inc
-
Columbus, Ohio, Estados Unidos, 43228
- Doctors Hospital
-
Columbus, Ohio, Estados Unidos, 43213
- Mount Carmel East Hospital
-
Columbus, Ohio, Estados Unidos, 43215
- Grant Medical Center
-
Columbus, Ohio, Estados Unidos, 43222
- Mount Carmel Health Center West
-
Dayton, Ohio, Estados Unidos, 45406
- Good Samaritan Hospital - Dayton
-
Dayton, Ohio, Estados Unidos, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Estados Unidos, 45415
- Miami Valley Hospital North
-
Dayton, Ohio, Estados Unidos, 45415
- Dayton Physician LLC - Englewood
-
Delaware, Ohio, Estados Unidos, 43015
- Delaware Health Center-Grady Cancer Center
-
Delaware, Ohio, Estados Unidos, 43015
- Delaware Radiation Oncology
-
Delaware, Ohio, Estados Unidos, 43015
- Grady Memorial Hospital
-
Dublin, Ohio, Estados Unidos, 43016
- Columbus Oncology and Hematology Associates
-
Elyria, Ohio, Estados Unidos, 44035
- Mercy Cancer Center-Elyria
-
Findlay, Ohio, Estados Unidos, 45840
- Blanchard Valley Hospital
-
Findlay, Ohio, Estados Unidos, 45840
- Armes Family Cancer Center
-
Findlay, Ohio, Estados Unidos, 45840
- Orion Cancer Care
-
Franklin, Ohio, Estados Unidos, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Franklin, Ohio, Estados Unidos, 45005
- Dayton Physicians LLC-Atrium
-
Gahanna, Ohio, Estados Unidos, 43230
- Central Ohio Breast and Endocrine Surgery
-
Greenville, Ohio, Estados Unidos, 45331
- Wayne Hospital
-
Greenville, Ohio, Estados Unidos, 45331
- Dayton Physicians LLC-Wayne
-
Grove City, Ohio, Estados Unidos, 43123
- Mount Carmel Grove City Hospital
-
Grove City, Ohio, Estados Unidos, 43123
- Zangmeister Center Grove City
-
Kettering, Ohio, Estados Unidos, 45429
- Kettering Medical Center
-
Kettering, Ohio, Estados Unidos, 45409
- Greater Dayton Cancer Center
-
Kettering, Ohio, Estados Unidos, 45420
- First Dayton Cancer Care
-
Lancaster, Ohio, Estados Unidos, 43130
- Fairfield Medical Center
-
Lima, Ohio, Estados Unidos, 45801
- Saint Rita's Medical Center
-
Mansfield, Ohio, Estados Unidos, 44903
- OhioHealth Mansfield Hospital
-
Marietta, Ohio, Estados Unidos, 45750
- Marietta Memorial Hospital
-
Marion, Ohio, Estados Unidos, 43302
- OhioHealth Marion General Hospital
-
Mayfield Heights, Ohio, Estados Unidos, 44124
- Hillcrest Hospital Cancer Center
-
Mentor, Ohio, Estados Unidos, 44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Middleburg Heights, Ohio, Estados Unidos, 44130
- UH Seidman Cancer Center at Southwest General Hospital
-
Mount Vernon, Ohio, Estados Unidos, 43050
- Knox Community Hospital
-
New Albany, Ohio, Estados Unidos, 43054
- Mount Carmel New Albany Surgical Hospital
-
Newark, Ohio, Estados Unidos, 43055
- Licking Memorial Hospital
-
Newark, Ohio, Estados Unidos, 43055
- Newark Radiation Oncology
-
Perrysburg, Ohio, Estados Unidos, 43551
- Mercy Health - Perrysburg Hospital
-
Portsmouth, Ohio, Estados Unidos, 45662
- Southern Ohio Medical Center
-
Sandusky, Ohio, Estados Unidos, 44870
- UH Seidman Cancer Center at Firelands Regional Medical Center
-
Springfield, Ohio, Estados Unidos, 45504
- Springfield Regional Cancer Center
-
Springfield, Ohio, Estados Unidos, 45504
- Springfield Regional Medical Center
-
Sylvania, Ohio, Estados Unidos, 43560
- ProMedica Flower Hospital
-
Toledo, Ohio, Estados Unidos, 43606
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
-
Toledo, Ohio, Estados Unidos, 43623
- Mercy Health - Saint Anne Hospital
-
Toledo, Ohio, Estados Unidos, 43608
- Mercy Health - Saint Vincent Hospital
-
Toledo, Ohio, Estados Unidos, 43623
- Mercy Health Sylvania Radiation Oncology Center
-
Troy, Ohio, Estados Unidos, 45373
- Upper Valley Medical Center
-
Troy, Ohio, Estados Unidos, 45373
- Dayton Physicians LLC - Troy
-
Wadsworth, Ohio, Estados Unidos, 44281
- University Hospitals Sharon Health Center
-
Warren, Ohio, Estados Unidos, 44484
- Saint Joseph Warren Hospital
-
Westerville, Ohio, Estados Unidos, 43081
- Saint Ann's Hospital
-
Westlake, Ohio, Estados Unidos, 44145
- UH Seidman Cancer Center at Saint John Medical Center
-
Westlake, Ohio, Estados Unidos, 44145
- UHHS-Westlake Medical Center
-
Youngstown, Ohio, Estados Unidos, 44501
- Saint Elizabeth Youngstown Hospital
-
Zanesville, Ohio, Estados Unidos, 43701
- Genesis Healthcare System Cancer Care Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Estados Unidos, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, Estados Unidos, 73120
- Mercy Hospital Oklahoma City
-
Tulsa, Oklahoma, Estados Unidos, 74146
- Oklahoma Cancer Specialists and Research Institute-Tulsa
-
-
Oregon
-
Baker City, Oregon, Estados Unidos, 97814
- Saint Alphonsus Cancer Care Center-Baker City
-
Bend, Oregon, Estados Unidos, 97701
- Saint Charles Health System
-
Clackamas, Oregon, Estados Unidos, 97015
- Clackamas Radiation Oncology Center
-
Clackamas, Oregon, Estados Unidos, 97015
- Providence Cancer Institute Clackamas Clinic
-
Coos Bay, Oregon, Estados Unidos, 97420
- Bay Area Hospital
-
Newberg, Oregon, Estados Unidos, 97132
- Providence Newberg Medical Center
-
Ontario, Oregon, Estados Unidos, 97914
- Saint Alphonsus Cancer Care Center-Ontario
-
Oregon City, Oregon, Estados Unidos, 97045
- Providence Willamette Falls Medical Center
-
Portland, Oregon, Estados Unidos, 97210
- Legacy Good Samaritan Hospital and Medical Center
-
Portland, Oregon, Estados Unidos, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Estados Unidos, 97225
- Providence Saint Vincent Medical Center
-
Redmond, Oregon, Estados Unidos, 97756
- Saint Charles Health System-Redmond
-
Tualatin, Oregon, Estados Unidos, 97062
- Legacy Meridian Park Hospital
-
-
Pennsylvania
-
Abington, Pennsylvania, Estados Unidos, 19001
- Jefferson Abington Hospital
-
Bryn Mawr, Pennsylvania, Estados Unidos, 19010
- Bryn Mawr Hospital
-
Chadds Ford, Pennsylvania, Estados Unidos, 19317
- Christiana Care Health System-Concord Health Center
-
Collegeville, Pennsylvania, Estados Unidos, 19426
- Main Line Health Center-Collegeville
-
Exton, Pennsylvania, Estados Unidos, 19341
- Main Line Health Center-Exton
-
Jefferson Hills, Pennsylvania, Estados Unidos, 15025
- Jefferson Hospital
-
Media, Pennsylvania, Estados Unidos, 19063
- Riddle Memorial Hospital
-
Monroeville, Pennsylvania, Estados Unidos, 15146
- Forbes Hospital
-
Paoli, Pennsylvania, Estados Unidos, 19301
- Paoli Memorial Hospital
-
Philadelphia, Pennsylvania, Estados Unidos, 19107
- Thomas Jefferson University Hospital
-
Pittsburgh, Pennsylvania, Estados Unidos, 15212
- Allegheny General Hospital
-
Pittsburgh, Pennsylvania, Estados Unidos, 15224
- West Penn Hospital
-
West Chester, Pennsylvania, Estados Unidos, 19380
- Chester County Hospital
-
West Reading, Pennsylvania, Estados Unidos, 19611
- Reading Hospital
-
Wexford, Pennsylvania, Estados Unidos, 15090
- Wexford Health and Wellness Pavilion
-
Willow Grove, Pennsylvania, Estados Unidos, 19090
- Asplundh Cancer Pavilion
-
Wynnewood, Pennsylvania, Estados Unidos, 19096
- Lankenau Medical Center
-
-
Rhode Island
-
Providence, Rhode Island, Estados Unidos, 02905
- Women and Infants Hospital
-
-
South Carolina
-
Anderson, South Carolina, Estados Unidos, 29621
- AnMed Health Cancer Center
-
Charleston, South Carolina, Estados Unidos, 29425
- Medical University of South Carolina
-
Gaffney, South Carolina, Estados Unidos, 29341
- Gibbs Cancer Center-Gaffney
-
Greenville, South Carolina, Estados Unidos, 29607
- Saint Francis Cancer Center
-
Greenville, South Carolina, Estados Unidos, 29601
- Saint Francis Hospital
-
Greer, South Carolina, Estados Unidos, 29651
- Gibbs Cancer Center-Pelham
-
Spartanburg, South Carolina, Estados Unidos, 29303
- Spartanburg Medical Center
-
Union, South Carolina, Estados Unidos, 29379
- SMC Center for Hematology Oncology Union
-
-
South Dakota
-
Sioux Falls, South Dakota, Estados Unidos, 57105
- Avera Cancer Institute
-
Sioux Falls, South Dakota, Estados Unidos, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, Estados Unidos, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Chattanooga, Tennessee, Estados Unidos, 37404
- Memorial Hospital
-
Hixson, Tennessee, Estados Unidos, 37343
- Pulmonary Medicine Center of Chattanooga-Hixson
-
Ooltewah, Tennessee, Estados Unidos, 37363
- Memorial GYN Plus
-
-
Texas
-
Austin, Texas, Estados Unidos, 78701
- Dell Seton Medical Center at The University of Texas
-
Bryan, Texas, Estados Unidos, 77802
- Saint Joseph Regional Cancer Center
-
Dallas, Texas, Estados Unidos, 75235
- Parkland Memorial Hospital
-
Dallas, Texas, Estados Unidos, 75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
Houston, Texas, Estados Unidos, 77026-1967
- Lyndon Baines Johnson General Hospital
-
Houston, Texas, Estados Unidos, 77030
- UT MD Anderson Cancer Center
-
Houston, Texas, Estados Unidos, 77030
- Houston Methodist Hospital
-
Houston, Texas, Estados Unidos, 77070
- Methodist Willowbrook Hospital
-
Sugar Land, Texas, Estados Unidos, 77479
- Houston Methodist Sugar Land Hospital
-
-
Washington
-
Aberdeen, Washington, Estados Unidos, 98520
- Providence Regional Cancer System-Aberdeen
-
Bellevue, Washington, Estados Unidos, 98004
- Overlake Medical Center
-
Bellingham, Washington, Estados Unidos, 98225
- PeaceHealth Saint Joseph Medical Center
-
Burien, Washington, Estados Unidos, 98166
- Saint Anne Hospital
-
Centralia, Washington, Estados Unidos, 98531
- Providence Regional Cancer System-Centralia
-
Edmonds, Washington, Estados Unidos, 98026
- Swedish Cancer Institute-Edmonds
-
Enumclaw, Washington, Estados Unidos, 98022
- Saint Elizabeth Hospital
-
Everett, Washington, Estados Unidos, 98201
- Providence Regional Cancer Partnership
-
Federal Way, Washington, Estados Unidos, 98003
- Saint Francis Hospital
-
Issaquah, Washington, Estados Unidos, 98029
- Swedish Cancer Institute-Issaquah
-
Kennewick, Washington, Estados Unidos, 99336
- Kadlec Clinic Hematology and Oncology
-
Lacey, Washington, Estados Unidos, 98503
- Providence Regional Cancer System-Lacey
-
Lakewood, Washington, Estados Unidos, 98499
- Saint Clare Hospital
-
Longview, Washington, Estados Unidos, 98632
- PeaceHealth Saint John Medical Center
-
Port Townsend, Washington, Estados Unidos, 98368
- Jefferson Healthcare
-
Poulsbo, Washington, Estados Unidos, 98370
- Harrison HealthPartners Hematology and Oncology-Poulsbo
-
Renton, Washington, Estados Unidos, 98055
- Valley Medical Center
-
Seattle, Washington, Estados Unidos, 98107
- Swedish Medical Center-Ballard Campus
-
Seattle, Washington, Estados Unidos, 98122
- Swedish Medical Center-First Hill
-
Seattle, Washington, Estados Unidos, 98195
- University of Washington Medical Center - Montlake
-
Seattle, Washington, Estados Unidos, 98112
- Kaiser Permanente Washington
-
Seattle, Washington, Estados Unidos, 98104
- Pacific Gynecology Specialists
-
Seattle, Washington, Estados Unidos, 98122-5711
- Swedish Medical Center-Cherry Hill
-
Sedro-Woolley, Washington, Estados Unidos, 98284
- PeaceHealth United General Medical Center
-
Shelton, Washington, Estados Unidos, 98584
- Providence Regional Cancer System-Shelton
-
Silverdale, Washington, Estados Unidos, 98383
- Saint Joseph Medical Center Hematology and Oncology - Silverdale
-
Tacoma, Washington, Estados Unidos, 98405
- Northwest Medical Specialties PLLC
-
Tacoma, Washington, Estados Unidos, 98405
- Franciscan Research Center-Northwest Medical Plaza
-
Vancouver, Washington, Estados Unidos, 98686
- Legacy Salmon Creek Hospital
-
Vancouver, Washington, Estados Unidos, 98664
- PeaceHealth Southwest Medical Center
-
Walla Walla, Washington, Estados Unidos, 99362
- Providence Saint Mary Regional Cancer Center
-
Yakima, Washington, Estados Unidos, 98902
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
-
Yelm, Washington, Estados Unidos, 98597
- Providence Regional Cancer System-Yelm
-
-
West Virginia
-
Charleston, West Virginia, Estados Unidos, 25304
- Vandalia Health/CAMC Institute for Academic Medicine
-
-
Wisconsin
-
Ashland, Wisconsin, Estados Unidos, 54806
- Duluth Clinic Ashland
-
Ashland, Wisconsin, Estados Unidos, 54806
- Northwest Wisconsin Cancer Center
-
Burlington, Wisconsin, Estados Unidos, 53105
- Aurora Cancer Care-Southern Lakes VLCC
-
Chippewa Falls, Wisconsin, Estados Unidos, 54729
- Marshfield Clinic-Chippewa Center
-
Eau Claire, Wisconsin, Estados Unidos, 54701
- Marshfield Medical Center-EC Cancer Center
-
Eau Claire, Wisconsin, Estados Unidos, 54701
- Mayo Clinic Health System-Eau Claire Clinic
-
Fond du Lac, Wisconsin, Estados Unidos, 54937
- Aurora Health Center-Fond du Lac
-
Germantown, Wisconsin, Estados Unidos, 53022
- Aurora Health Care Germantown Health Center
-
Grafton, Wisconsin, Estados Unidos, 53024
- Aurora Cancer Care-Grafton
-
Green Bay, Wisconsin, Estados Unidos, 54311
- Aurora BayCare Medical Center
-
Hayward, Wisconsin, Estados Unidos, 54843
- Essentia Health-Hayward Clinic
-
Kenosha, Wisconsin, Estados Unidos, 53142
- Aurora Cancer Care-Kenosha South
-
La Crosse, Wisconsin, Estados Unidos, 54601
- Gundersen Lutheran Medical Center
-
Ladysmith, Wisconsin, Estados Unidos, 54848
- Marshfield Medical Center - Ladysmith
-
Marinette, Wisconsin, Estados Unidos, 54143
- Aurora Bay Area Medical Group-Marinette
-
Marshfield, Wisconsin, Estados Unidos, 54449
- Marshfield Medical Center-Marshfield
-
Milwaukee, Wisconsin, Estados Unidos, 53209
- Aurora Cancer Care-Milwaukee
-
Milwaukee, Wisconsin, Estados Unidos, 53215
- Aurora Saint Luke's Medical Center
-
Milwaukee, Wisconsin, Estados Unidos, 53233
- Aurora Sinai Medical Center
-
Minocqua, Wisconsin, Estados Unidos, 54548
- Marshfield Medical Center - Minocqua
-
New Richmond, Wisconsin, Estados Unidos, 54017
- Cancer Center of Western Wisconsin
-
Oshkosh, Wisconsin, Estados Unidos, 54904
- Vince Lombardi Cancer Clinic - Oshkosh
-
Racine, Wisconsin, Estados Unidos, 53406
- Aurora Cancer Care-Racine
-
Rice Lake, Wisconsin, Estados Unidos, 54868
- Marshfield Medical Center-Rice Lake
-
Sheboygan, Wisconsin, Estados Unidos, 53081
- Vince Lombardi Cancer Clinic-Sheboygan
-
Spooner, Wisconsin, Estados Unidos, 54801
- Essentia Health-Spooner Clinic
-
Stevens Point, Wisconsin, Estados Unidos, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Summit, Wisconsin, Estados Unidos, 53066
- Aurora Medical Center in Summit
-
Superior, Wisconsin, Estados Unidos, 54880
- Essentia Health Saint Mary's Hospital - Superior
-
Two Rivers, Wisconsin, Estados Unidos, 54241
- Vince Lombardi Cancer Clinic-Two Rivers
-
Wausau, Wisconsin, Estados Unidos, 54401
- Marshfield Clinic-Wausau Center
-
Wauwatosa, Wisconsin, Estados Unidos, 53226
- Aurora Cancer Care-Milwaukee West
-
West Allis, Wisconsin, Estados Unidos, 53227
- Aurora West Allis Medical Center
-
Weston, Wisconsin, Estados Unidos, 54476
- Marshfield Medical Center - Weston
-
Wisconsin Rapids, Wisconsin, Estados Unidos, 54494
- Marshfield Clinic - Wisconsin Rapids Center
-
-
Wyoming
-
Cheyenne, Wyoming, Estados Unidos, 82001
- Cheyenne Regional Medical Center-West
-
Cody, Wyoming, Estados Unidos, 82414
- Billings Clinic-Cody
-
Sheridan, Wyoming, Estados Unidos, 82801
- Welch Cancer Center
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
-
Patients must have recurrent or persistent endometrial carcinoma, which is refractory to curative therapy or established treatments; histologic confirmation of the original primary tumor is required; patients with the following histologic epithelial cell types are eligible: endometrioid adenocarcinoma, serous adenocarcinoma, undifferentiated carcinoma, mixed epithelial carcinoma, adenocarcinoma not otherwise specified (N.O.S.); NOTE: clear cell and carcinosarcoma histology is excluded.
-
Patients must have measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 or non-measurable (detectable) disease
-
Measurable disease is defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded); each lesion must be >= 10 mm when measured by computed tomography (CT), magnetic resonance imaging (MRI) or caliper measurement by clinical exam; or >= 20 mm when measured by chest x-ray; lymph nodes must be > 15 mm in short axis when measured by CT or MRI; patients with measurable disease must have at least one "target lesion" to be used to assess response on this protocol as defined by RECIST version 1.1; tumors within a previously irradiated field will be designated as "non-target" lesions unless progression is documented or a biopsy is obtained to confirm persistence at least 90 days following completion of radiation therapy
-
Non-measurable (detectable) disease in a patient is defined in this protocol as one who does not have measurable disease but has at least one of the following conditions:
- Ascites and/or pleural effusion attributed to tumor;
- Solid and/or cystic abnormalities on radiographic imaging that do not meet RECIST 1.1 definitions for target lesions.
-
-
Patients must have signed an approved informed consent and authorization permitting release of personal health information.
-
Patients must have had one prior chemotherapeutic regimen for management of endometrial carcinoma; initial treatment may include chemotherapy, chemotherapy and radiation therapy, and/or consolidation/maintenance therapy; chemotherapy administered in conjunction with primary radiation as a radio-sensitizer WILL be counted as a systemic chemotherapy regimen.
-
Patients are allowed to receive, but are not required to receive, one additional cytotoxic regimen for management of recurrent or persistent disease according to the following definition: cytotoxic regimens include any agent that targets the genetic and/or mitotic apparatus of dividing cells, resulting in dose-limiting toxicity to the bone marrow and/or gastrointestinal mucosa; Note: patients on this non-cytotoxic study are allowed to receive one additional cytotoxic chemotherapy regimen for management of recurrent or persistent disease, as defined above; however, patients are encouraged to enroll on second-line non-cytotoxic studies prior to receiving additional cytotoxic therapy.
-
Patients may have received non cytotoxic therapy including immunotherapy (1 prior line in either upfront or recurrent setting) but excluding cediranib, olaparib, AZD5363 (capivasertib), durvalumab (MEDI4736), or the combination of lenvatinib and pembrolizumab for the management of recurrent or persistent disease; prior hormonal therapy is allowed; hormonal therapy for grade 1 endometrial cancers with low volume or indolent disease is encouraged.
-
Bevacizumab, or one course of single-agent immune-checkpoint therapy, excluding durvalumab (MEDI4736), is permitted prior to enrollment on this trial.
-
Body weight > 30 kg.
-
Age >= 18.
-
The trial is open to females only (including women with an intact uterus with uterine cancer); fertile females of childbearing potential need to agree to use adequate contraceptive measures from 2 weeks prior to the study and until 1 month after study treatment discontinuation, and have a negative serum or urine pregnancy test within 3 days prior to the start of study treatment.
-
Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0,1 or 2 (Karnofsky >= 60%) within 7 days prior to registration; patients should have no deterioration over the previous two weeks.
-
Hemoglobin >= 10 mg/dL with no blood transfusion in the past 28 days (within 28 days prior to administration of study drug).
-
Platelet count >= 100 x 10^9/L (within 28 days prior to administration of study drug).
-
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L (within 28 days prior to administration of study drug).
-
Patients must have creatinine clearance estimated of >= 51 mL/min using the Cockcroft Gault equation or based on a 24-hour urine test (within 28 days prior to administration of study drug).
-
Serum bilirubin =< 1.5 X upper limit of normal (ULN) (within 28 days prior to administration of study drug).
-
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< 3 x ULN (within 28 days prior to administration of study drug).
-
Urinalysis (dipstick) =< 1+ proteinuria OR urine protein creatinine ratio (UPCR) < 1 (within 28 days prior to administration of study drug).
-
Patients must be able to swallow and retain oral medications and without gastrointestinal illnesses that would preclude absorption of cediranib, olaparib, or AZD5363 (capivasertib).
-
Patients must have adequately controlled blood pressure (BP), with a BP no greater than 140 mmHg (systolic) and 90 mmHg (diastolic) for eligibility; patients must have a BP of =< 140/90 mmHg taken in the clinic setting by a medical professional within 2 weeks prior to starting study; patients with hypertension may be managed with up to a maximum of three antihypertensive medications; it is strongly recommended that patients who are on three antihypertensive medications be followed by a cardiologist or blood pressure specialist for management of blood pressure while on protocol.
- Note: Patients must be willing and able to check and record daily blood pressure readings.
-
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry.
-
Adequately controlled thyroid function, with no symptoms of thyroid dysfunction.
-
Postmenopausal or evidence of non-childbearing status for women of childbearing potential as confirmed by a negative urine or serum pregnancy test within 7 days prior to start of investigational products (IPs); postmenopausal is defined as:
-
Age >= 60 years, or
-
Age < 60 with any one or more of the conditions below:
- Amenorrheic for >= 1 year in the absence of chemotherapy and/or hormonal treatments,
- Luteinizing hormone and/or follicle stimulating hormone and/or estradiol levels in the post-menopausal range
- Radiation-induced oophorectomy with last menses > 1 year ago,
- Chemotherapy-induced menopause with > 1 year interval since last menses,
- Surgical sterilization (bilateral oophorectomy or hysterectomy).
-
-
Patients must have a life expectancy of greater than 16 weeks.
-
Patients with a previous diagnosis of immune or inflammatory colitis or chronic diarrhea > 1 month without immune or inflammatory colitis are eligible with adequately controlled colitis (no diarrhea greater than grade 1 for at least 28 days) and in the absence of symptoms related to colonic dysfunction; patients who required steroids for prior immune related colitis are not eligible.
-
Females of child-bearing potential should use two forms of highly reliable methods of contraception from the time of screening until 4 weeks after discontinuing study treatment.
-
Acceptable methods of contraception include:
- Established use of oral, injected or implanted hormonal methods of contraception.
- Placement of an intrauterine device or intrauterine system.
- Barrier methods of contraception: condom or occlusive cap (diaphragm or cervical/vault caps) with spermicidal foam/gel/film/cream/suppository.
- Male partner sterilization (with the appropriate post-vasectomy documentation of the absence of sperm in the ejaculate).
- True abstinence (i.e., not engaging in sexual activity for the total duration of study treatment and the treatment washout period is an acceptable practice; however, periodic abstinence, the rhythm method, and the withdrawal method are not acceptable methods of birth control).
- Bilateral tubal occlusion or salpingectomy
-
Acceptable non-hormonal birth control methods include:
- Total/True abstinence: When the patient refrains from any form of sexual intercourse and this is in line with their usual and/or preferred lifestyle; this must continue for the total duration of the trial and for at least 1 month after the last dose of study drug <<for 3 months after last dose for male patients>>. [Periodic abstinence (e.g., calendar, ovulation, symptothermal, post-ovulation methods, or declaration of abstinence solely for the duration of a trial) and withdrawal are not acceptable methods of contraception]
- Vasectomised sexual partner PLUS male condom. With participant assurance that partner received post-vasectomy confirmation of azoospermia.
- Tubal occlusion PLUS male condom
- Intrauterine device (IUD) PLUS male condom. Provided coils are copper-banded.
-
Acceptable hormonal methods:
- Normal and low dose combined oral pills PLUS male condom.
- Cerazette (desogestrel) PLUS male condom. Cerazette is currently the only highly efficacious progesterone-based pill.
- Hormonal shot or injection (e.g., Depo-Provera) PLUS male condom.
- Etonogestrel implants (e.g., Implanon, Norplant) PLUS male condom.
- Norelgestromin/EE transdermal system PLUS male condom
- Intrauterine system [IUS] device (e.g., levonorgestrel releasing IUS -Mirena) PLUS male condom.
- Intravaginal device (e.g., EE and etonogestrel) PLUS male condom.
-
Exclusion Criteria:
-
Prior enrollment into a clinical trial including cediranib or olaparib; Note: prior bevacizumab is not an exclusion criterion.
-
Prior enrollment into a clinical trial including cediranib, olaparib, AZD5363 (capivasertib), durvalumab (MEDI4736), or the combination of lenvatinib and pembrolizumab. Note: Prior bevacizumab or single-agent immune checkpoint blockade, excluding durvalumab (MEDI4736), is not an exclusion criterion.
-
Prior chemotherapy, endocrine therapy, radiotherapy, or investigational agents within 4 weeks.
-
More than one prior line of treatment with immune checkpoint blockade therapy.
-
Current signs/symptoms of bowel obstruction and/or signs/symptoms of bowel obstruction within the preceding 3 months.
-
History of gastrointestinal perforation; patients with a history of abdominal fistula will be considered eligible if the fistula was surgically repaired or has healed, there has been no evidence of fistula for at least 6 months, and patient is deemed to be at low risk of recurrent fistula.
-
Uncontrolled intercurrent illness including, but not limited to known ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, extensive interstitial bilateral lung disease on high resolution computed tomography (HRCT) scan or psychiatric illness/social situations that would limit compliance with study requirements.
-
Concomitant use of known strong cytochrome (CYP) 3A inhibitors (e.g., itraconazole, telithromycin, clarithromycin, protease inhibitors boosted with ritonavir or cobicistat, indinavir, saquinavir, nelfinavir, boceprevir, telaprevir) or moderate CYP3A inhibitors (e.g. ciprofloxacin, erythromycin, diltiazem, fluconazole, verapamil); the required washout period prior to starting study treatments is 2 weeks for strong inhibitors, and at least 1 week for moderate inhibitors.
-
Concomitant use of potent inhibitors or inducers of CYP3A4 within 2 weeks before the start of study treatment (3 weeks for St John's wort), or sensitive substrates of CYP3A4, CYP2C9 and/or CYP2D6 with a narrow therapeutic window within 1 week before the start of study treatment. Concomitant use of drugs known to prolong the QT interval within 5 half-lives of the first dose of study treatment.
-
Pregnant women are excluded from this study because cediranib and olaparib are agents with the potential for teratogenic or abortifacient effects; because there is an unknown but potential risk of adverse events in nursing infants secondary to treatment of the mother with cediranib and olaparib, breastfeeding should be discontinued if the mother is treated with cediranib or olaparib; these potential risks may also apply to other agents used in this study; for women of childbearing capacity a negative pregnancy test is required.
-
Known human immunodeficiency virus (HIV)-positive individuals are ineligible because of the potential for pharmacokinetic interactions between many anti-HIV drugs and cediranib, olaparib, and/or AZD5363 (capivasertib); in addition, these individuals are at increased risk of lethal infections when treated with marrow-suppressive therapy.
-
Known active hepatitis B or hepatitis C infection on antiviral treatment.
-
Prior history of stroke or transient ischemic attack within the last 6 months.
-
Left ventricular ejection fraction (LVEF) < lower limit of normal (LLN) per institutional guidelines, or < 55%, if threshold for normal not otherwise specified by institutional guidelines, for patients with the following risk factors:
- Prior treatment with anthracyclines
- Prior treatment with trastuzumab
- Prior central thoracic radiation therapy (RT), including exposure of heart to therapeutic doses of ionizing RT
- History of myocardial infarction within 6-12 months prior to start of IPs
- Prior history of other significant impaired cardiac function.
-
Patients with any of the following:
- History of myocardial infarction within 6 months prior to starting treatment
- Unstable angina
- Resting electrocardiogram (ECG) with clinically significant abnormal findings or with corrected QT interval (QTc) > 470 msec on 2 or more time points within a 24 hour period or family history of long QT syndrome
- New York Heart Association functional classification of III or IV.
-
Prior history of hypertensive crisis or hypertensive encephalopathy.
-
Major surgical procedure within 4 weeks prior to starting treatment; patients must have recovered from any effects of any major surgery and surgical wound should have healed prior to starting treatment.
-
History of intra-abdominal abscess within 3 months prior to starting treatment.
-
Patients may not use any complementary or alternative medicines including natural herbal products or folk remedies as they may interfere with the effectiveness of the study treatments.
-
No prior allogeneic bone marrow transplant or double umbilical cord blood transplantation (dUBCT).
-
Whole blood transfusions in the last 120 days prior to entry to the study (packed red blood cells and platelet transfusions are acceptable).
-
Patients with myelodysplastic syndrome (MDS)/treatment-related acute myeloid leukemia (t-AML) or with features suggestive of MDS/AML.
-
Central nervous system metastases:
- Symptomatic uncontrolled brain metastases requiring corticosteroid treatment; history of spinal cord compression unless after definitive treatment the patient has clinically stable disease (SD) for at least 28 days prior to starting IPs; in the absence of these features and in an asymptomatic patient a scan to confirm the absence of brain metastases is not required.
-
Other malignancy within the last 5 years except for:
- Curatively treated basal cell or squamous cell carcinoma of skin; in situ cancer of the cervix, ductal carcinoma in situ of the breast or stage 1, grade 1 endometrial carcinoma
- Curatively treated other solid tumors including lymphomas (without bone marrow involvement) with no evidence of disease for >= 5 years prior to start of IPs.
-
Persisting >= grade 2 Common Terminology Criteria for Adverse Events (CTCAE) toxicity (except alopecia and grade 2 peripheral neuropathy) from previous anti-cancer treatment(s).
-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cediranib, olaparib, AZD5363 (capivasertib), or durvalumab (MEDI4736).
-
Pneumonitis or moderate-severe pre-existing pulmonary disease.
-
Patients who have a diagnosis of immunodeficiency or are receiving systemic steroid therapy or any other form of immunosuppressive therapy within 7 days of enrollment.
- Premedication with steroids for CT scan contrast is allowed.
- Inhaled or topical corticosteroids are allowed.
- The use of mineralocorticoids (e.g., fludrocortisone) for patients with orthostatic hypotension or adrenocortical insufficiency is allowed.
- The use of physiologic doses of corticosteroids may be approved after consultation with the study chair.
-
Patients with active autoimmune disease or history of autoimmune disease that might recur, which may affect vital organ function or require immune suppressive treatment including systemic corticosteroids. This includes, but is not limited to, patients with a history of immune related neurologic disease, multiple sclerosis, autoimmune (demyelinating) neuropathy, Guillain-Barre syndrome, myasthenia gravis; systemic autoimmune disease such as SLE, connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome, or phospholipid syndrome because of the risk of recurrence or exacerbation of disease.
-
Patients with vitiligo, endocrine deficiencies including type I diabetes mellitus, thyroiditis managed with replacement hormones including physiologic corticosteroids are eligible.
-
Patients with rheumatoid arthritis and other arthropathies, Sjogren's syndrome and psoriasis controlled with topical medication and patients with positive serology, such as antinuclear antibodies (ANA), anti-thyroid antibodies should be evaluated for the presence of target organ involvement and potential need for systemic treatment but should otherwise be eligible.
-
Active infection including tuberculosis (clinical evaluation that includes clinical history, physical examination and radiographic findings, and tuberculosis [TB] testing in line with local practice).
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Arm I (cediranib maleate_reference group 1)
Patients in reference group 1 receive cediranib maleate PO QD. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study. |
Undergo blood sample collection
Otros nombres:
Undergo MUGA
Otros nombres:
Undergo bone marrow aspiration and biopsy
Otros nombres:
Undergo CT scan
Otros nombres:
Given PO
Otros nombres:
Undergo bone marrow aspiration and biopsy
Otros nombres:
Undergo Echo
Otros nombres:
|
|
Experimental: Arm II (olaparib)
Patients receive olaparib PO BID. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study. |
Undergo blood sample collection
Otros nombres:
Undergo MUGA
Otros nombres:
Undergo bone marrow aspiration and biopsy
Otros nombres:
Undergo CT scan
Otros nombres:
Given PO
Otros nombres:
Undergo bone marrow aspiration and biopsy
Otros nombres:
Undergo Echo
Otros nombres:
|
|
Experimental: Arm III (cediranib maleate, olaparib)
Patients receive olaparib PO BID and cediranib maleate PO QD. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study. |
Undergo blood sample collection
Otros nombres:
Undergo MUGA
Otros nombres:
Undergo bone marrow aspiration and biopsy
Otros nombres:
Undergo CT scan
Otros nombres:
Given PO
Otros nombres:
Given PO
Otros nombres:
Undergo bone marrow aspiration and biopsy
Otros nombres:
Undergo Echo
Otros nombres:
|
|
Experimental: Arm IV (olaparib, capivasertib)
Patients receive olaparib PO BID on days 1-28 and capivasertib PO BID on days 1-4 each week. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study. |
Undergo blood sample collection
Otros nombres:
Undergo MUGA
Otros nombres:
Undergo bone marrow aspiration and biopsy
Otros nombres:
Undergo CT scan
Otros nombres:
Given PO
Otros nombres:
Given PO
Otros nombres:
Undergo bone marrow aspiration and biopsy
Otros nombres:
Undergo Echo
Otros nombres:
|
|
Experimental: Arm V (olaparib, durvalumab)
Patients receive olaparib PO BID on days 1-28 and durvalumab IV on day 1. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study. |
Undergo blood sample collection
Otros nombres:
Undergo MUGA
Otros nombres:
Undergo bone marrow aspiration and biopsy
Otros nombres:
Undergo CT scan
Otros nombres:
Given PO
Otros nombres:
Given IV
Otros nombres:
Undergo bone marrow aspiration and biopsy
Otros nombres:
Undergo Echo
Otros nombres:
|
|
Experimental: Arm VI (cediranib maleate, durvalumab)
Patients receive cediranib maleate PO QD on days 1-5 each week and durvalumab IV on day 1 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study. |
Undergo blood sample collection
Otros nombres:
Undergo MUGA
Otros nombres:
Undergo bone marrow aspiration and biopsy
Otros nombres:
Undergo CT scan
Otros nombres:
Given PO
Otros nombres:
Given IV
Otros nombres:
Undergo bone marrow aspiration and biopsy
Otros nombres:
Undergo Echo
Otros nombres:
|
|
Experimental: Arm VII (cediranib maleate_reference group 2)
Patients in reference group 1 receive cediranib maleate PO QD. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study. |
Undergo blood sample collection
Otros nombres:
Undergo MUGA
Otros nombres:
Undergo CT scan
Otros nombres:
Given PO
Otros nombres:
Undergo bone marrow aspiration and biopsy
Otros nombres:
Undergo Echo
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Progression-free Survival
Periodo de tiempo: Scans were done every 8 weeks for the first year and then every 12 weeks thereafter until disease progression. Vital status was assessed every 3 months for 2 years and then every 6 months for 3 years (5-years total).
|
Progression-free survival is defined as the time from the date of study enrollment to the investigator-determined date of progression or death due to any cause, whichever occurs first. For individuals who are alive and progression-free, the censored time at risk will be defined as the time from the study enrollment date to the date of the patient's last radiographic disease assessment. |
Scans were done every 8 weeks for the first year and then every 12 weeks thereafter until disease progression. Vital status was assessed every 3 months for 2 years and then every 6 months for 3 years (5-years total).
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Overall Survival
Periodo de tiempo: Vital status was assessed every 3 months for 2 years and then every 6 months for 3 years (5-years total).
|
Overall survival is defined as the time from the date of study enrollment to the date of death regardless of cause. For those individuals who have no death reported at the time of the analysis, the censored time at risk will be assessed from the date of study enrollment to the date that the patient was last contacted and known to be alive. |
Vital status was assessed every 3 months for 2 years and then every 6 months for 3 years (5-years total).
|
|
Objective Tumor Response
Periodo de tiempo: Scans were done every 8 weeks for the first year; then every 12 weeks thereafter until disease progression is confirmed or up to 33 months.
|
Objective tumor response was assessed in patients with measurable disease by the site investigator using RECIST v1.1. Patients with complete or partial tumor response were considered to have a response. |
Scans were done every 8 weeks for the first year; then every 12 weeks thereafter until disease progression is confirmed or up to 33 months.
|
|
Incidence of Adverse Events
Periodo de tiempo: Toxicity was assessed every other week for the first 8 weeks of study therapy and every 8 weeks after the completion or termination of study therapy up to 50 months.
|
The number of patients who reported at least a grade 3 adverse event were assessed in those who initiated treatment. |
Toxicity was assessed every other week for the first 8 weeks of study therapy and every 8 weeks after the completion or termination of study therapy up to 50 months.
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Mutaciones en genes de reparación homólogos de ácido desoxirribonucleico (ADN)
Periodo de tiempo: Hasta 5 años
|
Hasta 5 años
|
|
|
Markers of Angiogenesis in Serial Plasma Samples
Periodo de tiempo: Up to 5 years
|
Will assess if markers of angiogenesis in serial plasma samples are associated with response to cediranib alone or in combination with olaparib. |
Up to 5 years
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Helen J Mackay, NRG Oncology
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
- Enfermedades urogenitales
- Enfermedades Genitales
- Enfermedades del sistema endocrino
- Neoplasias urogenitales
- Neoplasias por sitio
- Neoplasias
- Enfermedades urogenitales femeninas
- Enfermedades urogenitales femeninas y complicaciones del embarazo
- Neoplasias por tipo histológico
- Enfermedades Genitales Femeninas
- Neoplasias Glandulares y Epiteliales
- Adenocarcinoma
- Enfermedades Ováricas
- Enfermedades anexiales
- Neoplasias Genitales Femeninas
- Trastornos gonadales
- Carcinoma
- Neoplasias Uterinas
- Sarcoma
- Neoplasias De Tejidos Conectivos Y Blandos
- Neoplasias Complejas y Mixtas
- Neoplasias Endometriales
- Neoplasias Ováricas
- Carcinosarcoma
- Carcinoma Endometrioide
- Aminoácidos, péptidos y proteínas
- Proteínas
- Compuestos de azufre
- Químicos orgánicos
- Técnicas de investigación
- Terapéutica
- Técnicas de laboratorio clínico
- Técnicas y procedimientos de diagnóstico
- Diagnóstico
- Procedimientos quirúrgicos, operativo
- Terapia con drogas
- Técnicas citológicas
- Citodiagnóstico
- Anticuerpos
- Inmunoglobulinas
- Inmunoproteínas
- Proteínas de la sangre
- Globulinas séricas
- Globulinas
- Químicos inorgánicos
- Técnicas de diagnóstico, quirúrgico
- Isotipos de inmunoglobulina
- Sulfuros
- Aniones
- Iones
- Electrolitos
- Sulfuro de hidrógeno
- Inmunoglobulina G
- Biopsia
- Manejo de muestras
- Capivasertib
- durvalumab
- Disulfides
- olaparib
- cediranib
- Terapia de fluidos
Otros números de identificación del estudio
- NCI-2017-01672
- U10CA180868 (Subvención/contrato del NIH de EE. UU.)
- NCI-2017-01672 (Identificador de registro: CTRP (Clinical Trial Reporting Program))
- NRG-GY012 (Otro identificador: CTEP)
- NRG-GY012 (Otro identificador: NRG Oncology)
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .